Research History 1
-
- PresentOsaka University Graduate School of Medicine
2014年1月 日本がん免疫学会・評議員
2012年8月 血液疾患免疫療法学会・評議員
2012年4月 日本血液学会・代議員
2005年12月 近畿血液学地方会・評議員
2004年3月 International WT1 Conference・Organizing committee member
THE JAPANESE SOCIETY OF HEMATOLOGY
THE JAPANESE CANCER ASSOCIATION
International Conference on WT1 in Human Neoplasia
SIHDS
THE JAPANESE SOCIETY OF INTERNAL MEDICINE
Life sciences / Hematology and oncology /
Life sciences / Pathobiochemistry /
Enzyme-Linked Immunosorbent Assay for Antibodies Against the Tumor-Associated Antigen-Derived Cytotoxic T-Lymphocyte Epitope.
Yusuke Oji
Methods in molecular biology (Clifton, N.J.) Vol. 2821 p. 217-223 2024 Research paper (scientific journal)
WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1.
Yusuke Oji, Naoki Kagawa, Hideyuki Arita, Norifumi Naka, Ken-Ichiro Hamada, Hidetatsu Outani, Yasushi Shintani, Yoshito Takeda, Eiichi Morii, Kenzo Shimazu, Motoyuki Suzuki, Sumiyuki Nishida, Jun Nakata, Akihiro Tsuboi, Miki Iwai, Sae Hayashi, Rin Imanishi, Sayaka Ikejima, Mizuki Kanegae, Masahiro Iwamoto, Mayu Ikeda, Kento Yagi, Haruka Shimokado, Hiroko Nakajima, Kana Hasegawa, Soyoko Morimoto, Fumihiro Fujiki, Akira Nagahara, Atsushi Tanemura, Yutaka Ueda, Tsunekazu Mizushima, Masato Ohmi, Takayuki Ishida, Manabu Fujimoto, Norio Nonomura, Tadashi Kimura, Hidenori Inohara, Seiji Okada, Haruhiko Kishima, Naoki Hosen, Atsushi Kumanogoh, Yoshihiro Oka, Haruo Sugiyama
Cancers Vol. 15 No. 2 p. 393-393 2023/01/06 Research paper (scientific journal)
Publisher: MDPI AGWT1 epitope-specific IgG and IgM antibodies for immune-monitoring in patients with advanced sarcoma treated with a WT1 peptide cancer vaccine.
Shouq Alzaaqi, Norifumi Naka, Kenichiro Hamada, Naoki Hosen, Mizuki Kanegae, Hidetatsu Outani, Mayuko Adachi, Rin Imanishi, Eiichi Morii, Miki Iwai, Jun Nakata, Fumihiro Fujiki, Soyoko Morimoto, Hiroko Nakajima, Sumiyuki Nishida, Akihiro Tsuboi, Yoshihiro Oka, Haruo Sugiyama, Yusuke Oji
Oncology letters Vol. 23 No. 2 p. 65-65 2022/02 Research paper (scientific journal)
CAR T or NK cells targeting mismatched HLA-DR molecules in acute myeloid leukemia after allogeneic hematopoietic stem cell transplant
Shunya Ikeda, Kana Hasegawa, Yosuke Kogue, Takao Arimori, Ryuhei Kawamoto, Tansri Wibowo, Moto Yaga, Yuri Inada, Hirofumi Uehara, Miwa Matsubara, Mana Tachikawa, Makiko Suga, Shuhei Kida, Kumi Shibata, Kazuhito Tsutsumi, Kentaro Fukushima, Jiro Fujita, Tomoaki Ueda, Shinsuke Kusakabe, Akihisa Hino, Michiko Ichii, Asao Hirose, Hirohisa Nakamae, Masayuki Hino, Takafumi Nakao, Megumu Inoue, Kyoko Yoshihara, Satoshi Yoshihara, Shuji Ueda, Tetsuro Tachi, Hideki Kuroda, Koki Murakami, Noriyuki Kijima, Haruhiko Kishima, Eri Igashira, Mari Murakami, Tsuyoshi Takiuchi, Tadashi Kimura, Takashi Hiroshima, Toru Kimura, Yasushi Shintani, Chihaya Imai, Kosuke Yusa, Ryota Mori, Takayuki Ogino, Hidetoshi Eguchi, Kiyoshi Takeda, Yusuke Oji, Atsushi Kumanogoh, Junichi Takagi, Naoki Hosen
Nature Cancer 2025/03/24 Research paper (scientific journal)
Publisher: Springer Science and Business Media LLCCorrection: WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome.
Zwi N Berneman, Maxime De Laere, Paul Germonpré, Manon T Huizing, Yannick Willemen, Eva Lion, Hans De Reu, Jolien Van den Bossche, Jan Van den Brande, Pol Specenier, Sevilay Altintas, Peter A van Dam, Nathalie Cools, Griet Nijs, Barbara Stein, Kim Caluwaerts, Annemiek Snoeckx, Bart Op de Beeck, Kirsten Saevels, Lynn Rutsaert, Irma Vandenbosch, Gizem Oner, Martin Lammens, Pierre Van Damme, Sian Llewellyn-Lacey, David A Price, Yoshihiro Oka, Yusuke Oji, Haruo Sugiyama, Marie M Couttenye, Ann L Van de Velde, Viggo F Van Tendeloo, Marc Peeters, Sébastien Anguille, Evelien L J M Smits
Journal of hematology & oncology Vol. 18 No. 1 p. 34-34 2025/03/19
WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome.
Zwi N Berneman, Maxime De Laere, Paul Germonpré, Manon T Huizing, Yannick Willemen, Eva Lion, Hans De Reu, Jolien Van den Bossche, Jan Van den Brande, Pol Specenier, Sevilay Altintas, Peter A van Dam, Nathalie Cools, Griet Nijs, Barbara Stein, Kim Caluwaerts, Annemiek Snoeckx, Bart Op de Beeck, Kirsten Saevels, Lynn Rutsaert, Irma Vandenbosch, Gizem Oner, Martin Lammens, Pierre Van Damme, Sian Llewellyn-Lacey, David A Price, Yoshihiro Oka, Yusuke Oji, Haruo Sugiyama, Marie M Couttenye, Ann L Van de Velde, Viggo F Van Tendeloo, Marc Peeters, Sébastien Anguille, Evelien L J M Smits
Journal of hematology & oncology Vol. 18 No. 1 p. 9-9 2025/01/23 Research paper (scientific journal)
Spontaneous high clonal expansion of Wilms' tumor gene 1-specific cytotoxic T-lymphocytes in patients with Wilms' tumor gene 1-expressing solid tumor.
Soyoko Morimoto, Yukie Tanaka, Jun Nakata, Fumihiro Fujiki, Kana Hasegawa, Hiroko Nakajima, Sumiyuki Nishida, Akihiro Tsuboi, Naoki Hosen, Naoki Kagawa, Motohiko Maruno, Akira Myoui, Takayuki Enomoto, Shuichi Izumoto, Mitsugu Sekimoto, Naoya Hashimoto, Toshiki Yoshimine, Atsushi Kumanogoh, Yusuke Oji, Yoshihiro Oka, Haruo Sugiyama
Cancer immunology, immunotherapy : CII Vol. 74 No. 1 p. 15-15 2024/11/07 Research paper (scientific journal)
WT1発現固形癌患者におけるWT1特異的CTLの自然に発生したクローン性増殖
森本 創世子, 岡 芳弘, 藤木 文博, 田中 ゆきえ, 中田 潤, 中島 博子, 西田 純幸, 保仙 直毅, 坪井 昭博, 尾路 祐介, 杉山 治夫
日本がん免疫学会総会・日本バイオセラピィ学会学術集会総会合同大会プログラム・抄録集 Vol. 28回・37回 p. 154-154 2024/06
Publisher: 日本がん免疫学会・日本バイオセラピィ学会GEM併用WT1ワクチン投与膵癌患者からのWT1^126特異的high avidity TCRの単離
森本 創世子, 藤木 文博, 西田 純幸, 永田 暁教, 中田 潤, 中島 博子, 尾路 祐介, 岡 芳弘, 杉山 治夫
日本臨床免疫学会総会プログラム・抄録集 Vol. 51回 p. 121-121 2023/10
Publisher: (一社)日本臨床免疫学会若年健常者は腫瘍関連抗原特異的免疫応答を持つ(Tumor-associated antigen-specific immune responses in healthy young individuals)
高田 恭平, 大植 麻由, 森本 創世子, 中田 潤, 西田 純幸, 藤木 文博, 岡 芳弘, 杉山 治夫, 尾路 祐介
日本癌学会総会記事 Vol. 82回 p. 1021-1021 2023/09
Publisher: (一社)日本癌学会Establishment of a novel NFAT-GFP reporter platform useful for the functional avidity maturation of HLA class II-restricted TCRs.
Fumihiro Fujiki, Soyoko Morimoto, Yuya Nishida, Satoe Tanii, Nao Aoyama, Miki Inatome, Kento Inoue, Akiko Katsuhara, Hiroko Nakajima, Jun Nakata, Sumiyuki Nishida, Akihiro Tsuboi, Yoshihiro Oka, Yusuke Oji, Shinji Sogo, Haruo Sugiyama
Cancer immunology, immunotherapy : CII Vol. 72 No. 7 p. 2347-2356 2023/07 Research paper (scientific journal)
小児がんに対する免疫療法の現状 小児固形腫瘍に対するWT1ペプチドワクチン療法の有効性と免疫学的解析
橋井 佳子, 細谷 要介, 尾路 祐介, 坪井 昭博, 岡 芳弘, 大薗 恵一, 杉山 治夫
日本癌治療学会学術集会抄録集 Vol. 60回 p. OWS3-3 2022/10
Publisher: (一社)日本癌治療学会Serum WT1-271 IgM antibody as a novel diagnostic marker for Gastric Cancer.
Masaaki Ito, Yusuke Oji, Mayuko Adachi, Rin Imanishi, Shouq Alzaaqi, Takaki Hiwasa, Yoko Oshima, Satoshi Yajima, Takashi Suzuki, Tatsuki Nanami, Makoto Sumazaki, Fumiaki Shiratori, Kimihiko Funahashi, Haruo Sugiayama, Hideaki Shimada
Molecular and clinical oncology Vol. 16 No. 3 p. 74-74 2022/03 Research paper (scientific journal)
Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain.
Kana Hasegawa, Shunya Ikeda, Moto Yaga, Kouki Watanabe, Rika Urakawa, Akie Iehara, Mai Iwai, Seishin Hashiguchi, Soyoko Morimoto, Fumihiro Fujiki, Hiroko Nakajima, Jun Nakata, Sumiyuki Nishida, Akihiro Tsuboi, Yoshihiro Oka, Satoshi Yoshihara, Masahiro Manabe, Hiroyoshi Ichihara, Atsuko Mugitani, Yasutaka Aoyama, Takafumi Nakao, Asao Hirose, Masayuki Hino, Shiho Ueda, Katsuto Takenaka, Takashi Masuko, Koichi Akashi, Takahiro Maruno, Susumu Uchiyama, Shinji Takamatsu, Naoki Wada, Eiichi Morii, Shushi Nagamori, Daisuke Motooka, Yoshikatsu Kanai, Yusuke Oji, Tomoyoshi Nakagawa, Noriyuki Kijima, Haruhiko Kishima, Atsuyo Ikeda, Takayuki Ogino, Yasushi Shintani, Tateki Kubo, Emiko Mihara, Kosuke Yusa, Haruo Sugiyama, Junichi Takagi, Eiji Miyoshi, Atsushi Kumanogoh, Naoki Hosen
Science translational medicine Vol. 14 No. 632 2022/02/16 Research paper (scientific journal)
T Cell-Intrinsic Vitamin A Metabolism and Its Signaling Are Targets for Memory T Cell-Based Cancer Immunotherapy.
Fumihiro Fujiki, Soyoko Morimoto, Akiko Katsuhara, Akane Okuda, Saeka Ogawa, Eriko Ueda, Maki Miyazaki, Ayako Isotani, Masahito Ikawa, Sumiyuki Nishida, Hiroko Nakajima, Akihiro Tsuboi, Yoshihiro Oka, Jun Nakata, Naoki Hosen, Atsushi Kumanogoh, Yusuke Oji, Haruo Sugiyama
Frontiers in immunology Vol. 13 p. 935465-935465 2022 Research paper (scientific journal)
Cellular and Humoral Immune Responses Induced by an HLA Class I-restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer.
Sumiyuki Nishida, Soyoko Morimoto, Yusuke Oji, Satoshi Morita, Toshiaki Shirakata, Takayuki Enomoto, Akihiro Tsuboi, Yutaka Ueda, Kiyoshi Yoshino, Alzaaqi Shouq, Mizuki Kanegae, Satoshi Ohno, Fumihiro Fujiki, Hiroko Nakajima, Yoshiki Nakae, Jun Nakata, Naoki Hosen, Atsushi Kumanogoh, Yoshihiro Oka, Tadashi Kimura, Haruo Sugiyama
Journal of immunotherapy (Hagerstown, Md. : 1997) Vol. 45 No. 1 p. 56-66 2022/01/01 Research paper (scientific journal)
Publisher: Ovid Technologies (Wolters Kluwer Health)Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapy.
Chisato Yokota, Naoki Kagawa, Koji Takano, Yasuyoshi Chiba, Manabu Kinoshita, Noriyuki Kijima, Yusuke Oji, Yoshihiro Oka, Haruo Sugiyama, Akihiro Tsuboi, Shuichi Izumoto, Haruhiko Kishima, Naoya Hashimoto
Cancer immunology, immunotherapy : CII Vol. 71 No. 1 p. 189-201 2022/01 Research paper (scientific journal)
Identification of mouse helper epitopes for WT1-specific CD4+ T cells.
Hiroko Nakajima, Jun Nakata, Kanako Imafuku, Hiromu Hayashibara, Kazuki Isokawa, Keiko Udaka, Fumihiro Fujiki, Soyoko Morimoto, Kana Hasegawa, Naoki Hosen, Yoshiko Hashii, Sumiyuki Nishida, Akihiro Tsuboi, Yoshihiro Oka, Yusuke Oji, Shinji Sogo, Haruo Sugiyama
Cancer immunology, immunotherapy : CII Vol. 70 No. 11 p. 3323-3335 2021/11 Research paper (scientific journal)
Imaging Assessment of Tumor Response in the Era of Immunotherapy.
Jun Nakata, Kayako Isohashi, Yoshihiro Oka, Hiroko Nakajima, Soyoko Morimoto, Fumihiro Fujiki, Yusuke Oji, Akihiro Tsuboi, Atsushi Kumanogoh, Naoya Hashimoto, Jun Hatazawa, Haruo Sugiyama
Diagnostics (Basel, Switzerland) Vol. 11 No. 6 2021/06/05 Research paper (scientific journal)
Distinct difference in tumor-infiltrating immune cells between Wilms' tumor gene 1 peptide vaccine and anti-programmed cell death-1 antibody therapies.
Chisato Yokota, Jun Nakata, Koji Takano, Hiroko Nakajima, Hiromu Hayashibara, Hikaru Minagawa, Yasuyoshi Chiba, Ryuichi Hirayama, Noriyuki Kijima, Manabu Kinoshita, Yoshiko Hashii, Akihiro Tsuboi, Yoshihiro Oka, Yusuke Oji, Atsushi Kumanogoh, Haruo Sugiyama, Naoki Kagawa, Haruhiko Kishima
Neuro-oncology advances Vol. 3 No. 1 2021/01/01 Research paper (scientific journal)
Publisher: Oxford University Press (OUP)Identification of two distinct populations of WT1-specific cytotoxic T lymphocytes in co-vaccination of WT1 killer and helper peptides.
Fumihiro Fujiki, Akihiro Tsuboi, Soyoko Morimoto, Naoya Hashimoto, Miki Inatome, Hiroko Nakajima, Jun Nakata, Sumiyuki Nishida, Kana Hasegawa, Naoki Hosen, Yoshihiro Oka, Yusuke Oji, Shinji Sogo, Haruo Sugiyama
Cancer immunology, immunotherapy : CII Vol. 70 No. 1 p. 253-263 2021/01 Research paper (scientific journal)
Enhanced immune reaction resulting from co-vaccination of WT1 helper peptide assessed on PET-CT.
Jun Nakata, Kayako Isohashi, Soyoko Morimoto, Ryota Itou, Takashi Kamiya, Ai Matsuura, Hiroko Nakajima, Fumihiro Fujiki, Sumiyuki Nishida, Yoshiko Hasii, Kana Hasegawa, Shinichi Nakatsuka, Naoki Hosen, Akihiro Tsuboi, Yoshihiro Oka, Atsushi Kumanogoh, Masaru Shibano, Satoru Munakata, Yusuke Oji, Jun Hatazawa, Haruo Sugiyama
Medicine Vol. 99 No. 39 2020/09/25 Research paper (scientific journal)
Reader-free ELISPOT assay for immuno-monitoring in peptide-based cancer vaccine immunotherapy.
Sae Hayashi, Rin Imanishi, Mayuko Adachi, Sayaka Ikejima, Jun Nakata, Soyoko Morimoto, Fumihiro Fujiki, Sumiyuki Nishida, Akihiro Tsuboi, Naoki Hosen, Hiroko Nakajima, Kana Hasegawa, Yoshihiro Oka, Haruo Sugiyama, Yusuke Oji
Biomedical reports Vol. 12 No. 5 p. 244-250 2020/05 Research paper (scientific journal)
Encouraging Clinical Evolution of a Pediatric Patient With Relapsed Diffuse Midline Glioma Who Underwent WT1-Targeting Immunotherapy: A Case Report and Literature Review.
Yoshiko Hashii, Yoshihiro Oka, Naoki Kagawa, Naoya Hashimoto, Hiroyuki Saitou, Syogo Fukuya, Mizuki Kanegae, Sayaka Ikejima, Yusuke Oji, Keiichi Ozono, Akihiro Tsuboi, Haruo Sugiyama
Frontiers in oncology Vol. 10 p. 1188-1188 2020
Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments.
Sumiyuki Nishida, Akihiro Tsuboi, Atsushi Tanemura, Toshinori Ito, Hiroko Nakajima, Toshiaki Shirakata, Soyoko Morimoto, Fumihiro Fujiki, Naoki Hosen, Yusuke Oji, Atsushi Kumanogoh, Ichiro Kawase, Yoshihiro Oka, Ichiro Azuma, Satoshi Morita, Haruo Sugiyama
Medicine Vol. 98 No. 33 2019/08 Research paper (scientific journal)
What should we tackle next in acute myeloid leukemia? Wilms tumor gene 1 vaccine therapy would be a promising and versatile strategy for acute myeloid leukemia.
Jun Nakata, Yusuke Oji, Yoshihiro Oka, Haruo Sugiyama
Expert review of hematology Vol. 12 No. 4 p. 211-213 2019/04
A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma.
Akihiro Tsuboi, Naoya Hashimoto, Fumihiro Fujiki, Soyoko Morimoto, Naoki Kagawa, Hiroko Nakajima, Naoki Hosen, Sumiyuki Nishida, Jun Nakata, Satoshi Morita, Junichi Sakamoto, Yusuke Oji, Yoshihiro Oka, Haruo Sugiyama
Cancer immunology, immunotherapy : CII Vol. 68 No. 2 p. 331-340 2019/02 Research paper (scientific journal)
Extremely strong infiltration of WT1-specific CTLs into mouse tumor by the combination vaccine with WT1-specific CTL and helper peptides.
Jun Nakata, Hiroko Nakajima, Hiromu Hayashibara, Kanako Imafuku, Soyoko Morimoto, Fumihiro Fujiki, Daisuke Motooka, Daisuke Okuzaki, Kana Hasegawa, Naoki Hosen, Akihiro Tsuboi, Yoshihiro Oka, Atsushi Kumanogoh, Yusuke Oji, Haruo Sugiyama
Oncotarget Vol. 9 No. 89 p. 36029-36038 2018/11/13 Research paper (scientific journal)
Establishment of a novel platform cell line for efficient and precise evaluation of T cell receptor functional avidity.
Soyoko Morimoto, Fumihiro Fujiki, Kenta Kondo, Hiroko Nakajima, Yoshiki Kobayashi, Miki Inatome, Nao Aoyama, Yuya Nishida, Akihiro Tsuboi, Yoshihiro Oka, Sumiyuki Nishida, Jun Nakata, Naoki Hosen, Yusuke Oji, Haruo Sugiyama
Oncotarget Vol. 9 No. 75 p. 34132-34141 2018/09/25 Research paper (scientific journal)
CD98を標的とした多発性骨髄腫に対する新規抗体療法(CD98 is a novel target for antibody therapy against multiple myeloma)
池田 峻弥, 長谷川 加奈, 尾路 祐介, 杉山 治夫, 保仙 直毅
日本癌学会総会記事 Vol. 77回 p. 294-294 2018/09
Publisher: (一社)日本癌学会Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma.
Tomoya Kanai, Zensho Ito, Yusuke Oji, Machi Suka, Sumiyuki Nishida, Kazuki Takakura, Mikio Kajihara, Masayuki Saruta, Shuichi Fujioka, Takeyuki Misawa, Tadashi Akiba, Hiroyuki Yanagisawa, Shigetaka Shimodaira, Masato Okamoto, Haruo Sugiyama, Shigeo Koido
Oncology letters Vol. 16 No. 2 p. 2682-2692 2018/08 Research paper (scientific journal)
Wilms tumour 1 peptide vaccine as a cure-oriented post-chemotherapy strategy for patients with acute myeloid leukaemia at high risk of relapse.
Jun Nakata, Yoshiki Nakae, Manabu Kawakami, Soyoko Morimoto, Daisuke Motooka, Naoki Hosen, Fumihiro Fujiki, Hiroko Nakajima, Kana Hasegawa, Sumiyuki Nishida, Akihiro Tsuboi, Yusuke Oji, Yoshihiro Oka, Atsushi Kumanogoh, Haruo Sugiyama
British journal of haematology Vol. 182 No. 2 p. 287-290 2018/07
WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies.
Yusuke Oji, Masayoshi Inoue, Yoshito Takeda, Naoki Hosen, Yasushi Shintani, Manabu Kawakami, Takuya Harada, Yui Murakami, Miki Iwai, Mari Fukuda, Sumiyuki Nishida, Jun Nakata, Yoshiki Nakae, Satoshi Takashima, Toshiaki Shirakata, Hiroko Nakajima, Kana Hasegawa, Hiroshi Kida, Takashi Kijima, Soyoko Morimoto, Fumihiro Fujiki, Akihiro Tsuboi, Eiichi Morii, Satoshi Morita, Junichi Sakamoto, Atsushi Kumanogoh, Yoshihiro Oka, Meinoshin Okumura, Haruo Sugiyama
International journal of cancer Vol. 142 No. 11 p. 2375-2382 2018/06/01 Research paper (scientific journal)
The activated conformation of integrin β7 is a novel multiple myeloma-specific target for CAR T cell therapy.
Naoki Hosen, Yukiko Matsunaga, Kana Hasegawa, Hiroshi Matsuno, Yuki Nakamura, Mio Makita, Kouki Watanabe, Mikako Yoshida, Kei Satoh, Soyoko Morimoto, Fumihiro Fujiki, Hiroko Nakajima, Jun Nakata, Sumiyuki Nishida, Akihiro Tsuboi, Yoshihiro Oka, Masahiro Manabe, Hiroyoshi Ichihara, Yasutaka Aoyama, Atsuko Mugitani, Takafumi Nakao, Masayuki Hino, Ryosuke Uchibori, Keiya Ozawa, Yoshihiro Baba, Seitaro Terakura, Naoki Wada, Eiichi Morii, Junichi Nishimura, Kiyoshi Takeda, Yusuke Oji, Haruo Sugiyama, Junichi Takagi, Atsushi Kumanogoh
Nature medicine Vol. 23 No. 12 p. 1436-1443 2017/12 Research paper (scientific journal)
Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
Sebastien Anguille, Ann L. Van de Velde, Evelien L. Smits, Viggo F. Van Tendeloo, Gunnar Juliusson, Nathalie Cools, Griet Nijs, Barbara Stein, Eva Lion, Ann Van Driessche, Irma Vandenbosch, Anke Verlinden, Alain P. Gadisseur, Wilfried A. Schroyens, Ludo Muylle, Katrien Vermeulen, Marie-Berthe Maes, Kathleen Deiteren, Ronald Malfait, Emma Gostick, Martin Lammens, Marie M. Couttenye, Philippe Jorens, Herman Goossens, David A. Price, Kristin Ladell, Yoshihiro Oka, Fumihiro Fujiki, Yusuke Oji, Haruo Sugiyama, Zwi N. Berneman
BLOOD Vol. 130 No. 15 p. 1713-1721 2017/10 Research paper (scientific journal)
Regulation of Stemness in Carcinoma Cells
Jijun Hao, Juli Unternaehrer, Xiaojiang Cui, Ninghui Cheng, Yusuke Oji
Stem Cells International Vol. 2017 2017 Research paper (scientific journal)
Publisher: Hindawi LimitedWilms' Tumor Gene 1 (WT1) Peptide Vaccine Therapy for Hematological Malignancies: From CTL Epitope Identification to Recent Progress in Clinical Studies Including a Cure-Oriented Strategy.
Yoshihiro Oka, Akihiro Tsuboi, Jun Nakata, Sumiyuki Nishida, Naoki Hosen, Atsushi Kumanogoh, Yusuke Oji, Haruo Sugiyama
Oncology research and treatment Vol. 40 No. 11 p. 682-690 2017 Research paper (scientific journal)
A Zbtb7a proto-oncogene as a novel target for miR-125a.
Nozomi Hojo, Naoya Tatsumi, Nahoko Moriguchi, Akihide Matsumura, Soyoko Morimoto, Jun Nakata, Fumihiro Fujiki, Sumiyuki Nishida, Hiroko Nakajima, Akihiro Tsuboi, Yoshihiro Oka, Naoki Hosen, Seiji Hayashi, Haruo Sugiyama, Yusuke Oji
Molecular carcinogenesis Vol. 55 No. 12 p. 2001-2009 2016/12 Research paper (scientific journal)
Syndecan-4 as a biomarker to predict clinical outcome for glioblastoma multiforme treated with WT1 peptide vaccine.
Satoshi Takashima, Yoshihiro Oka, Fumihiro Fujiki, Soyoko Morimoto, Hiroko Nakajima, Yoshiki Nakae, Jun Nakata, Sumiyuki Nishida, Naoki Hosen, Naoya Tatsumi, Kenji Mizuguchi, Naoya Hashimoto, Yusuke Oji, Akihiro Tsuboi, Atsushi Kumanogoh, Haruo Sugiyama
Future science OA Vol. 2 No. 4 2016/12 Research paper (scientific journal)
Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide.
Yusuke Oji, Naoya Hashimoto, Akihiro Tsuboi, Yui Murakami, Miki Iwai, Naoki Kagawa, Yasuyoshi Chiba, Shuichi Izumoto, Olga Elisseeva, Ryo Ichinohasama, Junichi Sakamoto, Satoshi Morita, Hiroko Nakajima, Satoshi Takashima, Yoshiki Nakae, Jun Nakata, Manabu Kawakami, Sumiyuki Nishida, Naoki Hosen, Fumihiro Fujiki, Soyoko Morimoto, Mayuko Adachi, Masahiro Iwamoto, Yoshihiro Oka, Toshiki Yoshimine, Haruo Sugiyama
International journal of cancer Vol. 139 No. 6 p. 1391-401 2016/09/15 Research paper (scientific journal)
On periodic Kalman filters and multi-rate estimation
Kenji Fujimoto, Yusuke Oji, Kenichi Hamamoto
2016 IEEE Conference on Control Applications (CCA) 2016/09 Research paper (international conference proceedings)
Publisher: IEEEInduction of eEF2-specific antitumor CTL responses in vivo by vaccination with eEF2-derived 9mer-peptides.
Hiroko Nakajima, Yui Murakami, Eiichi Morii, Toshiki Akao, Naoya Tatsumi, Satoko Odajima, Mari Fukuda, Takao Machitani, Miki Iwai, Sayo Kawata, Nozomi Hojo, Yoshihiro Oka, Haruo Sugiyama, Yusuke Oji
Oncology reports Vol. 35 No. 4 p. 1959-66 2016/04 Research paper (scientific journal)
An Essential Role of the Avidity of T-Cell Receptor in Differentiation of Self-Antigen-reactive CD8+ T Cells.
Kenta Kondo, Fumihiro Fujiki, Hiroko Nakajima, Erika Yatsukawa, Soyoko Morimoto, Naoya Tatsumi, Sumiyuki Nishida, Jun Nakata, Yoshihiro Oka, Akihiro Tsuboi, Naoki Hosen, Yusuke Oji, Haruo Sugiyama
Journal of immunotherapy (Hagerstown, Md. : 1997) Vol. 39 No. 3 p. 127-39 2016/04 Research paper (scientific journal)
Glycosylation Status of CD43 Protein Is Associated with Resistance of Leukemia Cells to CTL-Mediated Cytolysis.
Kana Hasegawa, Satomi Tanaka, Fumihiro Fujiki, Soyoko Morimoto, Katsuhiko Nakano, Hiroko Kinoshita, Atsushi Okumura, Yuka Fujioka, Rika Urakawa, Hiroko Nakajima, Naoya Tatsumi, Jun Nakata, Satoshi Takashima, Sumiyuki Nishida, Akihiro Tsuboi, Yoshihiro Oka, Yusuke Oji, Eiji Miyoshi, Takako Hirata, Atsushi Kumanogoh, Haruo Sugiyama, Naoki Hosen
PloS one Vol. 11 No. 3 2016/03 Research paper (scientific journal)
WT1 peptide vaccine for the treatment of malignancies: Its development, recent progress, and future perspectives
Yoshihiro Oka, Akihiro Tsuboi, Hiroko Nakajima, Fumihiro Fujiki, Sumiyuki Nishida, Soyoko Morimoto, Jun Nakata, Yoshiki Nakae, Satoshi Takashima, Naoya Tatsumi, Naoki Hosen, Yusuke Oji, Haruo Sugiyama
Immunotherapy of Cancer: An Innovative Treatment Comes of Age p. 159-185 2016/02/22 Part of collection (book)
Publisher: Springer JapanDeficiency in WT1-targeting microRNA-125a leads to myeloid malignancies and urogenital abnormalities
N. Tatsumi, N. Hojo, O. Yamada, M. Ogawa, Y. Katsura, S. Kawata, E. Morii, H. Sakamoto, R. Inaba, A. Tsuda, I. Fukuda, N. Moriguchi, H. Hasuwa, M. Okabe, F. Fujiki, S. Nishida, H. Nakajima, A. Tsuboi, Y. Oka, N. Hosen, H. Sugiyama, Y. Oji
ONCOGENE Vol. 35 No. 8 p. 1003-1014 2016/02 Research paper (scientific journal)
Feasibility of Cancer Immunotherapy with WT1 Peptide Vaccination for Solid and Hematological Malignancies in Children.
Akihisa Sawada, Masami Inoue, Osamu Kondo, Kayo Yamada-Nakata, Takashi Ishihara, Yuko Kuwae, Masanori Nishikawa, Yasuhiro Ammori, Akihiro Tsuboi, Yusuke Oji, Maho Koyama-Sato, Yoshihiro Oka, Masahiro Yasui, Haruo Sugiyama, Keisei Kawa
Pediatric blood & cancer Vol. 63 No. 2 p. 234-41 2016/02 Research paper (scientific journal)
Wilms tumor 1 peptide vaccination after hematopoietic stem cell transplant in leukemia patients.
Naoki Hosen, Tetsuo Maeda, Yoshiko Hashii, Akihiro Tsuboi, Sumiyuki Nishida, Jun Nakata, Yusuke Oji, Yoshihiro Oka, Haruo Sugiyama
Stem cell investigation Vol. 3 p. 90-90 2016 Research paper (scientific journal)
Wilms' tumor gene WT1 promotes homologous recombination-mediated DNA damage repair.
Yusuke Oji, Naoya Tatsumi, Junya Kobayashi, Mari Fukuda, Tazu Ueda, Eri Nakano, Chisae Saito, Syohei Shibata, Mihoko Sumikawa, Hisashi Fukushima, Akari Saito, Nozomi Hojo, Miyu Suzuki, Tomoko Hoshikawa, Tsutomu Shimura, Eiichi Morii, Yoshihiro Oka, Naoki Hosen, Kenshi Komatsu, Haruo Sugiyama
Molecular carcinogenesis Vol. 54 No. 12 p. 1758-71 2015/12 Research paper (scientific journal)
An Immunocompetent Mouse Model for MLL/AF9 Leukemia Reveals the Potential of Spontaneous Cytotoxic T-Cell Response to an Antigen Expressed in Leukemia Cells.
Kana Hasegawa, Satomi Tanaka, Fumihiro Fujiki, Soyoko Morimoto, Hiroko Nakajima, Naoya Tatsumi, Jun Nakata, Satoshi Takashima, Sumiyuki Nishida, Akihiro Tsuboi, Yoshihiro Oka, Yusuke Oji, Atsushi Kumanogoh, Haruo Sugiyama, Naoki Hosen
PloS one Vol. 10 No. 12 2015/12 Research paper (scientific journal)
初発膠芽腫に対するテモゾロミド併用のWT1ペプチドワクチン療法
橋本 直哉, 坪井 昭博, 千葉 泰良, 香川 尚己, 有田 英之, 森本 創世子, 岡 芳弘, 尾路 祐介, 吉峰 俊樹, 杉山 治夫
日本癌学会総会記事 Vol. 74回 p. E-1223 2015/10
Publisher: 日本癌学会Two distinct effector memory cell populations of WT1 (Wilms' tumor gene 1)-specific cytotoxic T lymphocytes in acute myeloid leukemia patients.
Yoshiki Nakae, Yoshihiro Oka, Fumihiro Fujiki, Soyoko Morimoto, Toshio Kamiya, Satoshi Takashima, Jun Nakata, Sumiyuki Nishida, Hiroko Nakajima, Naoki Hosen, Akihiro Tsuboi, Taiichi Kyo, Yusuke Oji, Kenji Mizuguchi, Atsushi Kumanogoh, Haruo Sugiyama
Cancer immunology, immunotherapy : CII Vol. 64 No. 7 p. 791-804 2015/07 Research paper (scientific journal)
Central Nervous System Tumor:Glioma 脳腫瘍 グリオーマ 脳腫瘍に対するペプチドワクチン療法
橋本 直哉, 香川 尚己, 有田 英之, 坪井 昭博, 岡 芳弘, 尾路 祐介, 杉山 治夫, 吉峰 俊樹
癌と化学療法 Vol. 42 No. 6 p. 687-689 2015/06
Publisher: (株)癌と化学療法社[III. Peptide vaccination therapy against brain tumors].
Naoya Hashimoto, Naoki Kagawa, Hideyuki Arita, Akihiro Tsuboi, Yoshihiro Oka, Yusuke Oji, Haruo Sugiyama, Toshiki Yoshimine
Gan to kagaku ryoho. Cancer & chemotherapy Vol. 42 No. 6 p. 687-9 2015/06/01 Research paper (scientific journal)
Publisher: Japanese Journal of Cancer and Chemotherapy Publishers Inc.Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological response
Naoya Hashimoto, Akihiro Tsuboi, Naoki Kagawa, Yasuyoshi Chiba, Shuichi Izumoto, Manabu Kinoshita, Noriyuki Kijima, Yoshihiro Oka, Soyoko Morimoto, Hiroko Nakajima, Satoshi Morita, Junichi Sakamoto, Sumiyuki Nishida, Naoki Hosen, Yusuke Oji, Norio Arita, Toshiki Yoshimine, Haruo Sugiyama
CANCER IMMUNOLOGY IMMUNOTHERAPY Vol. 64 No. 6 p. 707-716 2015/06 Research paper (scientific journal)
Identification of a Novel C-Terminal Truncated WT1 Isoform with Antagonistic Effects against Major WT1 Isoforms.
Naoya Tatsumi, Nozomi Hojo, Hiroyuki Sakamoto, Rena Inaba, Nahoko Moriguchi, Keiko Matsuno, Mari Fukuda, Akihide Matsumura, Seiji Hayashi, Soyoko Morimoto, Jun Nakata, Fumihiro Fujiki, Sumiyuki Nishida, Hiroko Nakajima, Akihiro Tsuboi, Yoshihiro Oka, Naoki Hosen, Haruo Sugiyama, Yusuke Oji
PloS one Vol. 10 No. 6 2015/06 Research paper (scientific journal)
Transduction of a novel HLA-DRB1*04:05-restricted, WT1-specific TCR gene into human CD4+ T cells confers killing activity against human leukemia cells.
Akiko Katsuhara, Fumihiro Fujiki, Nao Aoyama, Satoe Tanii, Soyoko Morimoto, Yoshihiro Oka, Akihiro Tsuboi, Hiroko Nakajima, Kenta Kondo, Naoya Tatsumi, Jun Nakata, Yoshiki Nakae, Satoshi Takashima, Sumiyuki Nishida, Naoki Hosen, Shinji Sogo, Yusuke Oji, Haruo Sugiyama
Anticancer research Vol. 35 No. 3 p. 1251-61 2015/03 Research paper (scientific journal)
WT1 enhances proliferation and impedes apoptosis in KRAS mutant NSCLC via targeting cMyc.
Chen Wu, Sihan Wang, Caihua Xu, Andreas Tyler, Xingru Li, Charlotta Andersson, Yusuke Oji, Haruo Sugiyama, Yijiang Chen, Aihong Li
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology Vol. 35 No. 2 p. 647-62 2015 Research paper (scientific journal)
The Wilms' Tumor Gene WT1 - 17AA/- KTS Splice Variant Increases Tumorigenic Activity Through Up-Regulation of Vascular Endothelial Growth Factor in an In Vivo Ovarian Cancer Model.
Keiko Yamanouchi, Tsuyoshi Ohta, Zhiyang Liu, Yusuke Oji, Haruo Sugiyama, Viji Shridhar, Sohei Matsumura, Toshifumi Takahashi, Kazuhiro Takahashi, Hirohisa Kurachi
Translational oncology Vol. 7 No. 5 p. 580-9 2014/10 Research paper (scientific journal)
Publisher: Translational Oncology Editorial OfficeVaccination strategies to improve outcome of hematopoietic stem cell transplant in leukemia patients: early evidence and future prospects.
Naoki Hosen, Tetsuo Maeda, Yoshiko Hashii, Akihiro Tsuboi, Sumiyuki Nishida, Jun Nakata, Yoshiki Nakae, Satoshi Takashima, Yusuke Oji, Yoshihiro Oka, Atsushi Kumanogoh, Haruo Sugiyama
Expert review of hematology Vol. 7 No. 5 p. 671-81 2014/10 Research paper (scientific journal)
The Wilms' Tumor Gene WT1-17AA/-KTS Splice Variant Increases Tumorigenic Activity Through Up-Regulation of Vascular Endothelial Growth Factor in an In Vivo Ovarian Cancer Model
Keiko Yamanouchi, Tsuyoshi Ohta, Zhiyang Liu, Yusuke Oji, Haruo Sugiyama, Viji Shridhar, Sohei Matsumura, Toshifumi Takahashi, Kazuhiro Takahashi, Hirohisa Kurachi
Translational Oncology Vol. 7 No. 5 p. 580-589 2014/10 Research paper (scientific journal)
Prognostic significance of specific anti-WT1 IgG antibody level in plasma in patients with ovarian carcinoma.
Charlotta Andersson, Yusuke Oji, Nina Ohlson, Sihan Wang, Xingru Li, Ulrika Ottander, Eva Lundin, Haruo Sugiyama, Aihong Li
Cancer medicine Vol. 3 No. 4 p. 909-18 2014/08 Research paper (scientific journal)
In vivo eradication of MLL/ENL leukemia cells by NK cells in the absence of adaptive immunity
J. Nakata, K. Nakano, A. Okumura, Y. Mizutani, H. Kinoshita, M. Iwai, K. Hasegawa, S. Morimoto, F. Fujiki, N. Tatsumi, H. Nakajima, Y. Nakae, S. Nishida, A. Tsuboi, Y. Oji, Y. Oka, H. Sugiyama, A. Kumanogoh, N. Hosen
LEUKEMIA Vol. 28 No. 6 p. 1316-1325 2014/06 Research paper (scientific journal)
The translation elongation factor eEF2 is a novel tumor‑associated antigen overexpressed in various types of cancers.
Yusuke Oji, Naoya Tatsumi, Mari Fukuda, Shin-Ichi Nakatsuka, Sayaka Aoyagi, Erika Hirata, Isamu Nanchi, Fumihiro Fujiki, Hiroko Nakajima, Yumiko Yamamoto, Syohei Shibata, Michiyo Nakamura, Kana Hasegawa, Sayaka Takagi, Ikuyo Fukuda, Tomoko Hoshikawa, Yui Murakami, Masahide Mori, Masayoshi Inoue, Tetsuji Naka, Takeshi Tomonaga, Yoshifumi Shimizu, Masashi Nakagawa, Junichi Hasegawa, Riichiro Nezu, Hidenori Inohara, Shuichi Izumoto, Norio Nonomura, Toshiki Yoshimine, Meinoshin Okumura, Eiichi Morii, Hajime Maeda, Sumiyuki Nishida, Naoki Hosen, Akihiro Tsuboi, Yoshihiro Oka, Haruo Sugiyama
International journal of oncology Vol. 44 No. 5 p. 1461-9 2014/05 Research paper (scientific journal)
Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer.
Sumiyuki Nishida, Shigeo Koido, Yutaka Takeda, Sadamu Homma, Hideo Komita, Akitaka Takahara, Satoshi Morita, Toshinori Ito, Soyoko Morimoto, Kazuma Hara, Akihiro Tsuboi, Yoshihiro Oka, Satoru Yanagisawa, Yoichi Toyama, Masahiro Ikegami, Toru Kitagawa, Hidetoshi Eguchi, Hiroshi Wada, Hiroaki Nagano, Jun Nakata, Yoshiki Nakae, Naoki Hosen, Yusuke Oji, Toshio Tanaka, Ichiro Kawase, Atsushi Kumanogoh, Junichi Sakamoto, Yuichiro Doki, Masaki Mori, Toshifumi Ohkusa, Hisao Tajiri, Haruo Sugiyama
Journal of immunotherapy (Hagerstown, Md. : 1997) Vol. 37 No. 2 p. 105-14 2014/02 Research paper (scientific journal)
Wilms' tumor 1 is involved in tumorigenicity of glioblastoma by regulating cell proliferation and apoptosis.
Noriyuki Kijima, Naoki Hosen, Naoki Kagawa, Naoya Hashimoto, Manabu Kinoshita, Yusuke Oji, Haruo Sugiyama, Toshiki Yoshimine
Anticancer research Vol. 34 No. 1 p. 61-7 2014/01 Research paper (scientific journal)
eEF2の癌遺伝子様機能とeEF2特異的免疫応答の誘導(Oncogenic function of eEF2 in cancers and in vivo humoral and in vitro CTL responses against eEF2 protein)
尾路 祐介, 辰巳 直也, 福田 茉莉, 中塚 新一, 藤木 文博, 中島 博子, 長谷川 加奈, 根津 理一郎, 森井 英一, 坪井 昭博, 岡 芳弘, 杉山 治夫
日本癌学会総会記事 Vol. 72回 p. 367-367 2013/10
Publisher: (一社)日本癌学会WT1ペプチドワクチンを用いた小児悪性固形腫瘍に対する第I/II相臨床試験(WT1 based immunotherapy for pediatric patient with solid malignant tumor: Phase I/II clinical trial)
橋井 佳子, 岡 芳弘, 香川 尚己, 宮村 能子, 細谷 要介, 尾路 祐介, 坪井 昭博, 大薗 恵一, 杉山 治夫
日本癌学会総会記事 Vol. 72回 p. 153-153 2013/10
Publisher: 日本癌学会Peptide vaccination therapy targeting wilms' tumor 1 (WTl) gene products against malignant gliomas
Naoya Hashimoto, Yasuyoshi Chiba, Manabu Kinoshita, Naoki Kagawa, Akihiro Tsuboi, Yoshihiro Oka, Yusuke Oji, Haruo Sugiyama, Toshiki Yoshimine
Japanese Journal of Neurosurgery Vol. 22 No. 8 p. 619-624 2013/08/25 Research paper (scientific journal)
Publisher: Japanese Congress of Neurological SurgeonsFunctional human Th17 clones with WT1-specific helper activity.
Sho Tachino, Fumihiro Fujiki, Yoshihiro Oka, Akihiro Tsuboi, Soyoko Morimoto, Yu-Hung Lin, Taichi Tamanaka, Kenta Kondo, Hiroko Nakajima, Sumiyuki Nishida, Naoki Hosen, Yusuke Oji, Atsushi Kumanogoh, Haruo Sugiyama
Cancer immunology, immunotherapy : CII Vol. 62 No. 4 p. 801-10 2013/04 Research paper (scientific journal)
HLA-DPB1*05: 01-restricted WT1332-specific TCR-transduced CD4+ T lymphocytes display a helper activity for WT1-specific CTL induction and a cytotoxicity against leukemia cells.
Yuhung Lin, Fumihiro Fujiki, Akiko Katsuhara, Yoshihiro Oka, Akihiro Tsuboi, Nao Aoyama, Satoe Tanii, Hiroko Nakajima, Naoya Tatsumi, Soyoko Morimoto, Taichi Tamanaka, Sho Tachino, Naoki Hosen, Sumiyuki Nishida, Yusuke Oji, Atsushi Kumanogoh, Haruo Sugiyama
Journal of immunotherapy (Hagerstown, Md. : 1997) Vol. 36 No. 3 p. 159-70 2013/04 Research paper (scientific journal)
Identification of a Wilms' tumor 1-derived immunogenic CD4+ T-cell epitope that is recognized in the context of common Caucasian HLA-DR haplotypes
S. Anguille, F. Fujiki, E. L. Smits, Y. Oji, E. Lion, Y. Oka, Z. N. Berneman, H. Sugiyama
Leukemia Vol. 27 No. 3 p. 748-750 2013/03 Research paper (scientific journal)
WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: a phase II trial.
Takashi Miyatake, Yutaka Ueda, Akiko Morimoto, Takayuki Enomoto, Sumiyuki Nishida, Toshiaki Shirakata, Yoshihiro Oka, Akihiro Tsuboi, Yusuke Oji, Naoki Hosen, Shin-ichi Nakatsuka, Satoshi Morita, Junichi Sakamoto, Haruo Sugiyama, Tadashi Kimura
Journal of cancer research and clinical oncology Vol. 139 No. 3 p. 457-63 2013/03 Research paper (scientific journal)
Recognition of a natural WT1 epitope by a modified WT1 peptide-specific T-cell receptor.
Taichi Tamanaka, Yoshihiro Oka, Fumihiro Fujiki, Akihiro Tsuboi, Akiko Katsuhara, Hiroko Nakajima, Naoki Hosen, Sumiyuki Nishida, Yu-Hung Lin, Sho Tachino, Yoshiki Akatsuka, Kiyotaka Kuzushima, Yusuke Oji, Atsushi Kumanogoh, Haruo Sugiyama
Anticancer research Vol. 32 No. 12 p. 5201-9 2012/12 Research paper (scientific journal)
小児悪性神経膠腫に対するWT1ペプチドワクチン免疫療法
橋井 佳子, 香川 尚己, 橋本 直哉, 坪井 昭博, 岡 芳弘, 尾路 祐介, 楠木 重範, 岡田 秀雄, 杉山 治夫, 大薗 恵一
日本小児血液・がん学会学術集会・日本小児がん看護学会・公益財団法人がんの子どもを守る会公開シンポジウムプログラム総会号 Vol. 54回・10回・17回 p. 402-402 2012/11
Publisher: (NPO)日本小児血液・がん学会・(NPO)日本小児がん看護学会・(公財)がんの子供を守る会CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients
N. Hosen, Y. Matsuoka, S. Kishida, J. Nakata, Y. Mizutani, K. Hasegawa, A. Mugitani, H. Ichihara, Y. Aoyama, S. Nishida, A. Tsuboi, F. Fujiki, N. Tatsumi, H. Nakajima, M. Hino, T. Kimura, K. Yata, M. Abe, Y. Oka, Y. Oji, A. Kumanogoh, H. Sugiyama
LEUKEMIA Vol. 26 No. 9 p. 2135-2141 2012/09 Research paper (scientific journal)
Use of (11)C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma.
Yasuyoshi Chiba, Manabu Kinoshita, Yoshiko Okita, Akihiro Tsuboi, Kayako Isohashi, Naoki Kagawa, Yasunori Fujimoto, Yusuke Oji, Yoshihiro Oka, Eku Shimosegawa, Satoshi Morita, Jun Hatazawa, Haruo Sugiyama, Naoya Hashimoto, Toshiki Yoshimine
Journal of neurosurgery Vol. 116 No. 4 p. 835-42 2012/04 Research paper (scientific journal)
Biased usage of T cell receptor β-chain variable region genes of Wilms' tumor gene (WT1)-specific CD8+ T cells in patients with solid tumors and healthy donors.
Soyoko Morimoto, Yoshihiro Oka, Akihiro Tsuboi, Yukie Tanaka, Fumihiro Fujiki, Hiroko Nakajima, Naoki Hosen, Sumiyuki Nishida, Jun Nakata, Yoshiki Nakae, Motohiko Maruno, Akira Myoui, Takayuki Enomoto, Shuichi Izumoto, Mitsugu Sekimoto, Naoki Kagawa, Naoya Hashimoto, Toshiki Yoshimine, Yusuke Oji, Atsushi Kumanogoh, Haruo Sugiyama
Cancer science Vol. 103 No. 3 p. 408-14 2012/03 Research paper (scientific journal)
Biased usage of T cell receptor β-chain variable region genes of Wilms' tumor gene (WT1)-specific CD8+ T cells in patients with solid tumors and healthy donors.
Soyoko Morimoto, Yoshihiro Oka, Akihiro Tsuboi, Yukie Tanaka, Fumihiro Fujiki, Hiroko Nakajima, Naoki Hosen, Sumiyuki Nishida, Jun Nakata, Yoshiki Nakae, Motohiko Maruno, Akira Myoui, Takayuki Enomoto, Shuichi Izumoto, Mitsugu Sekimoto, Naoki Kagawa, Naoya Hashimoto, Toshiki Yoshimine, Yusuke Oji, Atsushi Kumanogoh, Haruo Sugiyama
Cancer science Vol. 103 No. 3 p. 408-14 2012/03 Research paper (scientific journal)
Vaccination with WT-1 (Wilms' tumor gene-1) peptide and BCG-CWS in melanoma.
Megumi Nishioka, Atsushi Tanemura, Sumiyuki Nishida, Akiko Nakano, Akihiro Tsuboi, Yusuke Oji, Yoshihiro Oka, Ichiro Azuma, Haruo Sugiyama, Ichiro Katayama
European journal of dermatology : EJD Vol. 22 No. 2 p. 258-9 2012/03
WT1 peptide therapy for a patient with chemotherapy-resistant salivary gland cancer.
Toshiaki Shirakata, Yoshihiro Oka, Sumiyuki Nishida, Naoki Hosen, Akihiro Tsuboi, Yusuke Oji, Ayako Murao, Hidetaka Tanaka, Shin-Ichi Nakatsuka, Hidenori Inohara, Haruo Sugiyama
Anticancer research Vol. 32 No. 3 p. 1081-5 2012/03 Research paper (scientific journal)
Low Wilms' tumor gene expression in tumor tissues predicts poor prognosis in patients with non-small-cell lung cancer.
Seiji Hayashi, Yusuke Oji, Yuko Kanai, Tomoaki Teramoto, Masanori Kitaichi, Tomoya Kawaguchi, Masaji Okada, Haruo Sugiyama, Akihide Matsumura
Cancer investigation Vol. 30 No. 2 p. 165-71 2012/02 Research paper (scientific journal)
Enhanced tumor immunity of WT1 peptide vaccination by interferon-β administration.
Hiroko Nakajima, Yoshihiro Oka, Akihiro Tsuboi, Naoya Tatsumi, Yumiko Yamamoto, Fumihiro Fujiki, Zheyu Li, Ayako Murao, Soyoko Morimoto, Naoki Hosen, Toshiaki Shirakata, Sumiyuki Nishida, Ichiro Kawase, Yoshitaka Isaka, Yusuke Oji, Haruo Sugiyama
Vaccine Vol. 30 No. 4 p. 722-9 2012/01/17 Research paper (scientific journal)
CD48 as a novel molecular target for antibody therapy in multiple myeloma.
Naoki Hosen, Hiroyoshi Ichihara, Atsuko Mugitani, Yasutaka Aoyama, Yuki Fukuda, Satoshi Kishida, Yoshikazu Matsuoka, Hiroko Nakajima, Manabu Kawakami, Tamotsu Yamagami, Shigeo Fuji, Hiroya Tamaki, Takafumi Nakao, Sumiyuki Nishida, Akihiro Tsuboi, Shinsuke Iida, Masayuki Hino, Yoshihiro Oka, Yusuke Oji, Haruo Sugiyama
British journal of haematology Vol. 156 No. 2 p. 213-24 2012/01 Research paper (scientific journal)
Expression of Wilms tumor 1 gene in a variety of pediatric tumors.
Takaharu Oue, Shuichiro Uehara, Hiroaki Yamanaka, Yuichi Takama, Yusuke Oji, Masahiro Fukuzawa
Journal of pediatric surgery Vol. 46 No. 12 p. 2233-8 2011/12 Research paper (scientific journal)
WT1 peptide-based immunotherapy following allogeneic stem cell transplantation in pediatric patients with acute leukemia
Yoshiko Hashii, Risa Matsumura, Hisao Yoshida, Emiko Miyashita, Hideaki Ohta, Akihiro Tsuboi, Yusuke Oji, Naoki Hosen, Yoshihiro Oka, Keiichi Ozono, Haruo Sugiyama
Biotherapy Vol. 25 No. 6 p. 851-856 2011/11/30 Research paper (scientific journal)
【がんペプチドワクチン療法の進歩と課題】同種造血幹細胞移植後の難治性小児血液腫瘍患者におけるWT1ペプチドワクチンを用いた免疫療法
橋井 佳子, 松村 梨紗, 吉田 寿雄, 宮下 恵実子, 太田 秀明, 坪井 昭博, 尾路 祐介, 保仙 直毅, 岡 芳弘, 大薗 恵一, 杉山 治夫
Biotherapy Vol. 25 No. 6 p. 851-856 2011/11
Publisher: (株)癌と化学療法社WT1ペプチドワクチンを用いた小児血液腫瘍に対する同種造血幹細胞移植後免疫療法(WT1 Peptide Vaccination Following Allogeneic Stem Cell Transplantation in Pediatric Leukemic Patients)
橋井 佳子, 坪井 昭博, 尾路 祐介, 保仙 直毅, 岡 芳弘, 杉山 治夫
日本癌学会総会記事 Vol. 70回 p. 432-432 2011/09
Publisher: 日本癌学会悪性グリオーマに対するWT1ペプチドワクチン療法 Recursive partitioning analysis(RPA)と予後予測因子
橋本 直哉, 千葉 泰良, 木嶋 教行, 有田 英之, 木下 学, 香川 尚己, 藤本 康倫, 吉峰 俊樹, 坪井 昭博, 尾路 祐介, 岡 芳弘, 杉山 治夫
日本がん免疫学会総会プログラム・抄録集 Vol. 15回 p. 79-79 2011/06
Publisher: 日本がん免疫学会同種造血幹細胞移植後の難治性小児血液腫瘍患者に対するWT1ペプチドワクチンを用いた免疫療法
橋井 佳子, 松村 梨紗, 吉田 寿雄, 宮下 恵実子, 坪井 昭博, 尾路 祐介, 保仙 直毅, 岡 芳弘, 杉山 治夫, 大薗 恵一
日本がん免疫学会総会プログラム・抄録集 Vol. 15回 p. 86-86 2011/06
Publisher: 日本がん免疫学会神経芽腫におけるWT1遺伝子の発現と腫瘍増殖への関与
大植 孝治, 王 景福, 野村 元成, 山中 宏晃, 上原 秀一郎, 高間 勇一, 尾路 祐介, 福澤 正洋
日本外科学会雑誌 Vol. 112 No. 臨増1-2 p. 481-481 2011/05
Publisher: (一社)日本外科学会[WT1 peptide-based immunotherapy for the treatment of malignancies: focusing on hematological neoplasms].
Yoshihiro Oka, Akihiro Tsuboi, Sumiyuki Nishida, Naoki Hosen, Jun Nakata, Yoshiko Hashii, Tetsuo Maeda, Yusuke Oji, Atsushi Kumanogoh, Haruo Sugiyama
[Rinsho ketsueki] The Japanese journal of clinical hematology Vol. 52 No. 5 p. 235-42 2011/05 Research paper (scientific journal)
The role of WT1 gene in neuroblastoma.
Jingfu Wang, Takaharu Oue, Shuichiro Uehara, Hiroaki Yamanaka, Yusuke Oji, Masahiro Fukuzawa
Journal of pediatric surgery Vol. 46 No. 2 p. 326-31 2011/02 Research paper (scientific journal)
同種造血幹細胞移植後の難治性小児血液腫瘍患者に対するWT1ペプチドワクチンを用いた免疫療法
橋井 佳子, 太田 秀明, 松村 梨紗, 吉田 寿雄, 楠木 重範, 佐藤 恵実子, 坪井 昭博, 尾路 祐介, 岡 芳弘, 杉山 治夫, 大薗 恵一
小児がん Vol. 47 No. プログラム・総会号 p. 292-292 2010/12
Publisher: (NPO)日本小児がん学会Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways
R. T. Sitaram, S. Degerman, B. Ljungberg, E. Andersson, Y. Oji, H. Sugiyama, G. Roos, A. Li
BRITISH JOURNAL OF CANCER Vol. 103 No. 8 p. 1255-1262 2010/10 Research paper (scientific journal)
WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient.
Yusuke Oji, Yoshihiro Oka, Sumiyuki Nishida, Akihiro Tsuboi, Manabu Kawakami, Toshiaki Shirakata, Kazuko Takahashi, Ayako Murao, Hiroko Nakajima, Miwako Narita, Masuhiro Takahashi, Satoshi Morita, Junichi Sakamoto, Toshio Tanaka, Ichiro Kawase, Naoki Hosen, Haruo Sugiyama
European journal of haematology Vol. 85 No. 4 p. 358-60 2010/10 Research paper (scientific journal)
WT1ペプチドがん免疫療法の現状と将来 WT1ペプチドワクチンによる再発させない同種造血幹細胞移植 小児白血病に対して
橋井 佳子, 松村 梨紗, 吉田 寿雄, 楠木 重範, 佐藤 恵実子, 太田 秀明, 坪井 昭博, 尾路 祐介, 保仙 直毅, 岡 芳弘, 杉山 治夫, 大薗 恵一
日本癌治療学会誌 Vol. 45 No. 2 p. 450-450 2010/09
Publisher: (一社)日本癌治療学会Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination.
Viggo F Van Tendeloo, Ann Van de Velde, Ann Van Driessche, Nathalie Cools, Sébastien Anguille, Kristin Ladell, Emma Gostick, Katrien Vermeulen, Katrien Pieters, Griet Nijs, Barbara Stein, Evelien L Smits, Wilfried A Schroyens, Alain P Gadisseur, Inge Vrelust, Philippe G Jorens, Herman Goossens, I Jolanda de Vries, David A Price, Yusuke Oji, Yoshihiro Oka, Haruo Sugiyama, Zwi N Berneman
Proceedings of the National Academy of Sciences of the United States of America Vol. 107 No. 31 p. 13824-9 2010/08/03 Research paper (scientific journal)
Prognostic significance of WT1 mRNA and anti-WT1 antibody levels in peripheral blood in patients with myelodysplastic syndromes.
Hideto Tamura, Kazuo Dan, Norio Yokose, Rika Iwakiri, Masatsugu Ohta, Hisashi Sakamaki, Kaoru Tohyama, Asaka Kondo, Hideya Hyodo, Kyoko Nakamura, Taishi Yamashita, Olga A Elisseeva, Yoshihiro Oka, Yusuke Oji, Haruo Sugiyama, Kiyoyuki Ogata
Leukemia research Vol. 34 No. 8 p. 986-90 2010/08 Research paper (scientific journal)
A clear correlation between WT1-specific Th response and clinical response in WT1 CTL epitope vaccination.
Fumihiro Fujiki, Yoshihiro Oka, Mai Kawakatsu, Akihiro Tsuboi, Yukie Tanaka-Harada, Naoki Hosen, Sumiyuki Nishida, Toshiaki Shirakata, Hiroko Nakajima, Naoya Tatsumi, Naoya Hashimoto, Tetsuya Taguchi, Satsuki Ueda, Norio Nonomura, Yutaka Takeda, Toshinori Ito, Akira Myoui, Shuichi Izumoto, Motohiko Maruno, Toshiki Yoshimine, Shinzaburo Noguchi, Akihiko Okuyama, Ichiro Kawase, Yusuke Oji, Haruo Sugiyama
Anticancer research Vol. 30 No. 6 p. 2247-54 2010/06 Research paper (scientific journal)
Effects of concomitant temozolomide and radiation therapies on WT1-specific T-cells in malignant glioma.
Yasuyoshi Chiba, Naoya Hashimoto, Akihiro Tsuboi, Yoshihiro Oka, Ayako Murao, Manabu Kinoshita, Naoki Kagawa, Yusuke Oji, Naoki Hosen, Sumiyuki Nishida, Haruo Sugiyama, Toshiki Yoshimine
Japanese journal of clinical oncology Vol. 40 No. 5 p. 395-403 2010/05 Research paper (scientific journal)
Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide.
Ryo Ichinohasama, Yusuke Oji, Hisayuki Yokoyama, Kengo Takeuchi, Tohru Fujiwara, Kenichi Ishizawa, Osamu Taniguchi, Akihiro Tsuboi, Yoshihiro Oka, Haruo Sugiyama
Cancer science Vol. 101 No. 5 p. 1089-92 2010/05 Research paper (scientific journal)
High frequencies of less differentiated and more proliferative WT1-specific CD8+ T cells in bone marrow in tumor-bearing patients: an important role of bone marrow as a secondary lymphoid organ.
Ayako Murao, Yoshihiro Oka, Akihiro Tsuboi, Olga A Elisseeva, Yukie Tanaka-Harada, Fumihiro Fujiki, Hiroko Nakajima, Sumiyuki Nishida, Naoki Hosen, Toshiaki Shirakata, Nobuyuki Hashimoto, Akira Myoui, Takafumi Ueda, Yoshito Takeda, Tadashi Osaki, Takayuki Enomoto, Hideki Yoshikawa, Tadashi Kimura, Yusuke Oji, Ichiro Kawase, Haruo Sugiyama
Cancer science Vol. 101 No. 4 p. 848-54 2010/04 Research paper (scientific journal)
Prognostic value of WT1 protein expression level and MIB-1 staining index as predictor of response to WT1 immunotherapy in glioblastoma patients.
Yasuyoshi Chiba, Naoya Hashimoto, Akihiro Tsuboi, Carter Rabo, Yoshihiro Oka, Manabu Kinoshita, Naoki Kagawa, Yusuke Oji, Haruo Sugiyama, Toshiki Yoshimine
Brain tumor pathology Vol. 27 No. 1 p. 29-34 2010/04 Research paper (scientific journal)
Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8+ T cells in patients with myeloid malignancies.
Yukie Tanaka-Harada, Manabu Kawakami, Yoshihiro Oka, Akihiro Tsuboi, Takamasa Katagiri, Olga A Elisseeva, Sumiyuki Nishida, Toshiaki Shirakata, Naoki Hosen, Fumihiro Fujiki, Ayako Murao, Hiroko Nakajima, Yusuke Oji, Yoshinobu Kanda, Ichiro Kawase, Haruo Sugiyama
Cancer science Vol. 101 No. 3 p. 594-600 2010/03 Research paper (scientific journal)
Prognostic Significance of WT1 mRNA and Anti-WT1 Antibody Levels in Peripheral Blood in Patients with Myelodysplastic Syndromes.
Hideto Tamura, Kazuo Dan, Norio Yokose, Rika Iwakiri, Masatsugu Ohta, Hisashi Sakamaki, Kaoru Tohyama, Kondo Asaka, Hideya Hyodo, Kyoko Nakamura, Taishi Yamashita, Olga A. Elisseeva, Yoshihiro Oka, Yusuke Oji, Haruo Sugiyama, Kiyoyuki Ogata
BLOOD Vol. 114 No. 22 p. 1470-1470 2009/11
WT1 peptide vaccine as a paradigm for "cancer antigen-derived peptide"-based immunotherapy for malignancies: successful induction of anti-cancer effect by vaccination with a single kind of WT1 peptide.
Yoshihiro Oka, Akihiro Tsuboi, Fumihiro Fujiki, Zheyu Li, Hiroko Nakajima, Naoki Hosen, Toshiaki Shirakata, Sumiyuki Nishida, Yusuke Oji, Ichiro Kawase, Haruo Sugiyama
Anti-cancer agents in medicinal chemistry Vol. 9 No. 7 p. 787-97 2009/09 Research paper (scientific journal)
WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor.
Yusuke Oji, Yayoi Kitamura, Eriko Kamino, Aiko Kitano, Noriyoshi Sawabata, Masayoshi Inoue, Masahide Mori, Shin-ichi Nakatsuka, Nao Sakaguchi, Kaori Miyazaki, Michiyo Nakamura, Ikuyo Fukuda, Junya Nakamura, Naoya Tatsumi, Tetsuya Takakuwa, Sumiyuki Nishida, Toshiaki Shirakata, Naoki Hosen, Akihiro Tsuboi, Riichiro Nezu, Hajime Maeda, Yoshihiro Oka, Ichiro Kawase, Katsuyuki Aozasa, Meinoshin Okumura, Shinichiro Miyoshi, Haruo Sugiyama
International journal of cancer Vol. 125 No. 2 p. 381-7 2009/07/15 Research paper (scientific journal)
WT1 peptide vaccination for the treatment of hematological malignancies: the present status and future direction.
Yoshihiro Oka, Akihiro Tsuboi, Toshiaki Shirakata, Naoki Hosen, Sumiyuki Nishida, Yusuke Oji, Haruo Sugiyama
[Rinsho ketsueki] The Japanese journal of clinical hematology Vol. 50 No. 5 p. 352-7 2009/05 Research paper (scientific journal)
Overexpression of eukaryotic elongation factor eEF2 in gastrointestinal cancers and its involvement in G2/M progression in the cell cycle.
Junya Nakamura, Sayaka Aoyagi, Isamu Nanchi, Shin-Ichi Nakatsuka, Erika Hirata, Shohei Shibata, Mari Fukuda, Yumiko Yamamoto, Ikuyo Fukuda, Naoya Tatsumi, Tazu Ueda, Fumihiro Fujiki, Masaya Nomura, Sumiyuki Nishida, Toshiaki Shirakata, Naoki Hosen, Akihoro Tsuboi, Yoshihiro Oka, Riichiro Nezu, Masaki Mori, Yuichiro Doki, Katsuyuki Aozasa, Haruo Sugiyama, Yusuke Oji
International journal of oncology Vol. 34 No. 5 p. 1181-9 2009/05 Research paper (scientific journal)
WT1 (Wilms tumor 1) peptide immunotherapy for childhood rhabdomyosarcoma: a case report.
Hideaki Ohta, Yoshiko Hashii, Akihiro Yoneda, Sachiko Takizawa, Shigenori Kusuki, Sadao Tokimasa, Masahiro Fukuzawa, Akihiro Tsuboi, Ayako Murao, Yoshihiro Oka, Yusuke Oji, Katsuyuki Aozasa, Shin-ichi Nakatsuka, Haruo Sugiyama, Keiichi Ozono
Pediatric hematology and oncology Vol. 26 No. 1 p. 74-83 2009/01 Research paper (scientific journal)
"Cancer antigen WT1 protein-derived peptide"-based treatment of cancer -toward the further development.
Yoshihiro Oka, Akihiro Tsuboi, Fumihiro Fujiki, Toshiaki Shirakata, Sumiyuki Nishida, Naoki Hosen, Hiroko Nakajima, Zheyu Li, Ichiro Kawase, Yusuke Oji, Haruo Sugiyama
Current medicinal chemistry Vol. 15 No. 29 p. 3052-61 2008/12 Research paper (scientific journal)
A WT1 protein-derived, naturally processed 16-mer peptide, WT1(332), is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4(+) T cells.
Fumihiro Fujiki, Yoshihiro Oka, Mai Kawakatsu, Akihiro Tsuboi, Hiroko Nakajima, Olga A Elisseeva, Yukie Harada, Zheyu Li, Naoko Tatsumi, Eriko Kamino, Toshiaki Shirakata, Sumiyuki Nishida, Yuki Taniguchi, Ichiro Kawase, Yusuke Oji, Haruo Sugiyama
Microbiology and immunology Vol. 52 No. 12 p. 591-600 2008/12 Research paper (scientific journal)
小児悪性腫瘍に対するWT1ワクチンの投与経験
橋井 佳子, 吉田 寿雄, 楠木 重範, 佐藤 恵実子, 時政 定雄, 太田 秀明, 米田 光宏, 澤田 明久, 井上 雅美, 坪井 昭博, 尾路 祐介, 岡 芳弘, 福沢 正洋, 河 敬世, 杉山 治夫, 大薗 恵一
小児がん Vol. 45 No. プログラム・総会号 p. 199-199 2008/11
Publisher: (NPO)日本小児がん学会Identification of a WT1 protein-derived peptide, WT1, as a HLA-A 0206-restricted, WT1-specific CTL epitope.
Zheyu Li, Yoshihiro Oka, Akihiro Tsuboi, Fumihiro Fujiki, Yukie Harada, Hiroko Nakajima, Tomoki Masuda, Yoko Fukuda, Mai Kawakatsu, Soyoko Morimoto, Takamasa Katagiri, Naoya Tatsumi, Naoki Hosen, Toshiaki Shirakata, Sumiyuki Nishida, Yutaka Kawakami, Keiko Udaka, Ichiro Kawase, Yusuke Oji, Haruo Sugiyama
Microbiology and immunology Vol. 52 No. 11 p. 551-8 2008/11 Research paper (scientific journal)
Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme
Shuichi Izumoto, Akihiro Tsuboi, Yoshihiro Oka, Tsuyoshi Suzuki, Tetsuo Hashiba, Naoki Kagawa, Naoya Hashimoto, Motohiko Maruno, Olga A. Elisseeva, Toshiaki Shirakata, Manabu Kawakami, Yusuke Oji, Sumiyuki Nishida, Satoshi Ohno, Ichiro Kawase, Jun Hatazawa, Shin-icih Nakatsuka, Katsuyuki Aozasa, Satoshi Morita, Junichi Sakamoto, Haruo Sugiyama, Toshiki Yosihmine
JOURNAL OF NEUROSURGERY Vol. 108 No. 5 p. 963-971 2008/05 Research paper (scientific journal)
WT1 peptide vaccine for the treatment of cancer
Yoshihiro Oka, Akihiro Tsuboi, Yusuke Oji, Ichiro Kawase, Haruo Sugiyama
CURRENT OPINION IN IMMUNOLOGY Vol. 20 No. 2 p. 211-220 2008/04
Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors
Naoya Tatsumi, Yusuke Oji, Naoko Tsuji, Asako Tsuda, Mari Higashio, Sayaka Aoyagi, Ikuyo Fukuda, Ken Ito, Junya Nakamura, Satoshi Takashima, Yayoi Kitamura, Saori Miyav, Tanyarat Jomgeow, Zheyu Li, Toshiaki Shirakata, Sumiyuki Nishida, Akihiro Tsuboi, Yoshihiro Oka, Haruo Sugiyama
INTERNATIONAL JOURNAL OF ONCOLOGY Vol. 32 No. 3 p. 701-711 2008/03 Research paper (scientific journal)
進行胞巣型横紋筋肉腫に対してWT1ペプチド免疫療法を試みた1例
太田 秀明, 橋井 佳子, 吉田 寿雄, 滝沢 祥子, 楠木 重範, 時政 定雄, 米田 光宏, 福澤 正洋, 坪井 昭博, 尾路 祐介, 岡 芳弘, 杉山 治夫, 大薗 恵一
小児がん Vol. 44 No. プログラム・総会号 p. 220-220 2007/12
Publisher: (NPO)日本小児がん学会Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma
Akihiro Tsuboi, Yoshihiro Oka, Hiroko Nakajima, Yoko Fukuda, Olga A. Elisseeva, Satoshi Yoshihara, Naoki Hosen, Atsushi Ogata, Katsuyuki Kito, Fumihiro Fujiki, Sumiyuki Nishida, Toshiaki Shirakata, Satoshi Ohno, Masaki Yasukawa, Yusuke Oji, Manabu Kawakami, Satoshi Morita, Junichi Sakamoto, Keiko Udaka, Ichiro Kawase, Haruo Sugiyama
INTERNATIONAL JOURNAL OF HEMATOLOGY Vol. 86 No. 5 p. 414-417 2007/12 Research paper (scientific journal)
The Wilms' tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis
N. Hosen, T. Shirakata, S. Nishida, M. Yanagihara, A. Tsuboi, M. Kawakami, Y. Oji, Y. Oka, M. Okabe, B. Tan, H. Sugiyama, I. L. Weissman
LEUKEMIA Vol. 21 No. 8 p. 1783-1791 2007/08 Research paper (scientific journal)
Clinical and immunologic responses to very low-dose vaccination with WT1 peptide (5 mu g/body) in a patient with chronic myelomonocytic leukemia
Manabu Kawakami, Yoshihiro Oka, Akihiro Tsuboi, Yukie Harada, Olga A. Elisseeva, Yoshio Furukawa, Machiko Tsukaguchi, Toshiaki Shirakata, Sumiyuki Nishida, Hiroko Nakajima, Satoshi Morita, Junichi Sakamoto, Ichiro Kawase, Yusuke Oji, Haruo Sugiyama
INTERNATIONAL JOURNAL OF HEMATOLOGY Vol. 85 No. 5 p. 426-429 2007/06 Research paper (scientific journal)
CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia
Naoki Hosen, Christopher Y. Park, Naoya Tatsumi, Yusuke Oji, Haruo Sugiyama, Martin Gramatzki, Alan M. Krensky, Irving L. Weissman
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA Vol. 104 No. 26 p. 11008-11013 2007/06 Research paper (scientific journal)
WT1 peptide cancer vaccine for patients with hematopoietic malignancies and solid cancers.
Oka Y, Tsuboi A, Elisseeva OA, Nakajima H, Fujiki F, Kawakami M, Shirakata T, Nishida S, Hosen N, Oji Y, Kawase I, Sugiyama H
TheScientificWorldJournal Vol. 7 p. 649-665 2007/05
Identification and characterization of a WT1 (Wilms tumor gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytes
Fumihiro Fujiki, Yoshihiro Oka, Akihiro Tsuboi, Manabu Kawakami, Mai Kawakatsu, Hiroko Nakajima, Olga A. Elisseeva, Yukie Harada, Ken Ito, Zheyu Li, Naoya Tatsumi, Nao Sakaguchi, Tatsuya Fujioka, Tomoki Masuda, Masaki Yasukawa, Keiko Udaka, Ichiro Kawase, Yusuke Oji, Haruo Sugiyama
JOURNAL OF IMMUNOTHERAPY Vol. 30 No. 3 p. 282-293 2007/04 Research paper (scientific journal)
WT1 peptide cancer vaccine for patients with hematopoietic malignancies and solid cancers
Yoshihiro Oka, Akihiro Tsuboi, Olga A. Elisseeva, Hiroko Nakajima, Fumihiro Fujiki, Manabu Kawakami, Toshiaki Shirakata, Sumiyuki Nishida, Naoki Hosen, Yusuke Oji, Ichiro Kawase, Haruo Sugiyama
THESCIENTIFICWORLDJOURNAL Vol. 7 p. 649-665 2007 Research paper (scientific journal)
Antiapoptotic function of 17AA(+) WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway
K. Ito, Y. Oji, N. Tatsumi, S. Shimizu, Y. Kanai, T. Nakazawa, M. Asada, T. Jomgeow, S. Aoyagi, Y. Nakano, H. Tamaki, N. Sakaguchi, T Shirakata, S. Nishida, M. Kawakami, A. Tsuboi, Y. Oka, Y. Tsujimoto, H. Sugiyama
ONCOGENE Vol. 25 No. 30 p. 4217-4229 2006/07 Research paper (scientific journal)
Immunohistochemical detection of WT1 protein in a variety of cancer cells
S Nakatsuka, Y Oji, T Horiuchi, T Kanda, M Kitagawa, T Takeuchi, K Kawano, Y Kuwae, A Yamauchi, M Okumura, Y Kitamura, Y Oka, Kawase, I, H Sugiyama, K Aozasa
MODERN PATHOLOGY Vol. 19 No. 6 p. 804-814 2006/06 Research paper (scientific journal)
Prognostic significance of Wilms tumor gene (WT1) mRNA expression in soft tissue sarcoma
T Sotobori, T Ueda, Y Oji, N Naka, N Araki, A Myoui, H Sugiyama, H Yoshikawa
CANCER Vol. 106 No. 10 p. 2233-2240 2006/05 Research paper (scientific journal)
AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1.
S Nishida, N Hosen, T Shirakata, K Kanato, M Yanagihara, S Nakatsuka, Y Hoshida, T Nakazawa, Y Harada, N Tatsumi, A Tsuboi, M Kawakami, Y Oka, Y Oji, K Aozasa, Kawase, I, H Sugiyama
BLOOD Vol. 107 No. 8 p. 3303-3312 2006/04 Research paper (scientific journal)
A phase I/II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: Safety assessment based on the phase I data
S Morita, Y Oka, A Tsuboi, M Kawakami, M Maruno, S Izumoto, T Osaki, T Taguchi, T Ueda, A Myoui, S Nishida, T Shirakata, S Ohno, Y Oji, K Aozasa, J Hatazawa, K Udaka, H Yoshikawa, T Yoshimine, S Noguchi, Kawase, I, SI Nakatsuka, H Sugiyama, J Sakamoto
JAPANESE JOURNAL OF CLINICAL ONCOLOGY Vol. 36 No. 4 p. 231-236 2006/04 Research paper (scientific journal)
Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro
T Jomgeow, Y Oji, N Tsuji, Y Ikeda, K Ito, A Tsuda, T Nakazawa, N Tatsumi, N Sakaguchi, S Takashima, T Shirakata, S Nishida, N Hosen, M Kawakami, A Tsuboi, Y Oka, K Itoh, H Sugiyama
CANCER SCIENCE Vol. 97 No. 4 p. 259-270 2006/04 Research paper (scientific journal)
P-50 神経芽腫におけるWT1遺伝子発現の検討(示説12 腫瘍1,第43回 日本小児外科学会総会)
米田 光宏, 草深 竹志, 奈良 啓悟, 田中 夏美, 尾路 祐介, 杉山 治夫, 福澤 正洋
日本小児外科学会雑誌 Vol. 42 No. 3 p. 444-444 2006
Publisher: 特定非営利活動法人 日本小児外科学会OP-302 WT1抗原を標的とした泌尿器科癌に対するペプチドワクチン療法の第I/II相臨床試験(一般演題口演,第94回日本泌尿器科学会総会)
飯山 達雄, 宇高 恵子, 竹内 保, 大朏 祐治, 中島 博子, 岡 芳弘, 坪井 昭博, 尾路 祐介, 杉山 治夫, 執印 太郎
日本泌尿器科学会雑誌 Vol. 97 No. 2 p. 356-356 2006
Publisher: 一般社団法人 日本泌尿器科学会WT1(235), a ninemer peptide derived from Wilms' tumor gene product, is a candidate peptide for the vaccination of HLA-A*0201-positive patients with hematopoietic malignancies
ZY Li, Y Oka, A Tsuboi, T Masuda, N Tatsumi, M Kawakami, T Fujioka, N Sakaguchi, H Nakajima, F Fujiki, K Udaka, Y Oji, Kawase, I, H Sugiyama
INTERNATIONAL JOURNAL OF HEMATOLOGY Vol. 82 No. 5 p. 458-459 2005/12
Th1-biased humoral immune responses against Wilms tumor gene WT1 product in the patients with hematopoietic malignancies
F Wu, Y Oka, A Tsuboi, OA Elisseeva, K Ogata, H Nakajima, F Fujiki, T Masuda, M Murakami, S Yoshihara, K Ikegame, N Hosen, M Kawakami, M Nakagawa, T Kubota, T Soma, T Yamagami, M Tsukaguchi, H Ogawa, Y Oji, T Hamaoka, Kawase, I, H Sugiyama
LEUKEMIA Vol. 19 No. 2 p. 268-274 2005/02 Research paper (scientific journal)
The Wilms' tumor gene WT1 is a common marker of progenitor cells in fetal liver
K Kanato, N Hosen, M Yanagihara, N Nakagata, T Shirakata, T Nakazawa, S Nishida, A Tsuboi, M Kawakami, T Masuda, Y Oka, Y Oji, A IJpenberg, ND Hastie, H Sugiyama
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS Vol. 326 No. 4 p. 836-843 2005/01 Research paper (scientific journal)
Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors
Y Oji, T Suzuki, Y Nakano, M Maruno, S Nakatsuka, T Jomgeow, S Abeno, N Tatsumi, A Yokota, S Aoyagi, T Nakazawa, K Ito, K Kanato, T Shirakata, S Nishida, N Hosen, M Kawakami, A Tsuboi, Y Oka, K Aozasa, T Yoshimine, H Sugiyama
CANCER SCIENCE Vol. 95 No. 10 p. 822-827 2004/10 Research paper (scientific journal)
Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression
Y Oka, A Tsuboi, T Taguchi, T Osaki, T Kyo, H Nakajima, OA Elisseeva, Y Oji, M Kawakami, K Ikegame, N Hosen, S Yoshihara, F Wu, F Fujiki, M Murakami, T Masuda, S Nishida, T Shirakata, S Nakatsuka, A Sasaki, K Udaka, H Dohy, K Aozasa, S Noguchi, L Kawase, H Sugiyama
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA Vol. 101 No. 38 p. 13885-13890 2004/09 Research paper (scientific journal)
Overexpression of the Wilms' tumor gene WT1 in esophageal cancer
Y Oji, M Yano, Y Nakano, S Abeno, S Nakatsuka, A Ikeba, T Yasuda, Y Fujiwara, S Takiguchi, H Yamamoto, S Fujita, K Kanato, K Ito, T Jomgeow, M Kawakami, A Tsuboi, T Shirakata, S Nishida, N Hosen, Y Oka, K Aozasa, M Monden, H Sugiyama
ANTICANCER RESEARCH Vol. 24 No. 5B p. 3103-3108 2004/09 Research paper (scientific journal)
Primary lung involvement with amyloid deposition in Waldenström's macroglobulinemia: Observations from over 20 years
Miyuki Okuda, Yasuhisa Okuda, Takeshi Ogura, Makoto Kashio, Tomiya Masuno, Yusuke Oji, Masayuki Miyazaki
Respirology Vol. 9 No. 3 p. 414-418 2004/08 Research paper (scientific journal)
Powerful graft-versus-leukemia effects exerted by HLA-haploidentical grafts engrafted with a reduced-intensity regimen for relapse following myeloablative HLA-matched transplantation
H Ogawa, K Ikegame, M Kawakami, A Tsuboi, EH Kim, N Hosen, M Murakami, T Fujioka, T Masuda, Y Taniguchi, S Yoshihara, T Tatekawa, Y Oka, Kawase, I, T Soma, Y Oji
TRANSPLANTATION Vol. 78 No. 3 p. 488-489 2004/08
WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone
H Nakajima, K Kawasaki, Y Oka, A Tsuboi, M Kawakami, K Ikegame, Y Hoshida, F Fujiki, A Nakano, T Masuda, F Wu, Y Taniguchi, S Yoshihara, OA Elisseeva, Y Oji, H Ogawa, Azuma, I, Kawase, I, K Aozasa, H Sugiyama
CANCER IMMUNOLOGY IMMUNOTHERAPY Vol. 53 No. 7 p. 617-624 2004/07 Research paper (scientific journal)
Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma
Y Oji, S Nakamori, M Fujikawa, SI Nakatsuka, A Yokota, N Tatsumi, S Abeno, A Ikeba, S Takashima, M Tsujie, H Yamamoto, M Sakon, R Nezu, K Kawano, S Nishida, K Ikegame, M Kawakami, A Tsuboi, Y Oka, K Yoshikawa, K Aozasa, M Monden, H Sugiyama
CANCER SCIENCE Vol. 95 No. 7 p. 583-587 2004/07 Research paper (scientific journal)
Identification of a gene element essential for leukemia-specific expression of transgenes
N Hosen, M Yanagihara, T Nakazawa, K Kanato, S Nishida, T Shirakata, M Asada, T Masuda, Y Taniguchi, M Kawakami, A Tsuboi, K Ikegame, Y Oka, H Ogawa, Kawase, I, Y Oji, H Sugiyama
LEUKEMIA Vol. 18 No. 3 p. 415-419 2004/03 Research paper (scientific journal)
Absence of mutations in the Wilms' tumor gene WT1 in primary breast cancer
Y Oji, Y Miyoshi, E Kiyotoh, S Koga, Y Nakano, A Ando, N Hosen, A Tsuboi, M Kawakami, K Ikegame, Y Oka, H Ogawa, S Noguchi, H Sugiyama
JAPANESE JOURNAL OF CLINICAL ONCOLOGY Vol. 34 No. 2 p. 74-77 2004/02 Research paper (scientific journal)
Absence of mutations in the Wilms' tumor gene wt1 in de novo non-small cell lung cancers
Y Oji, S Miyoshi, E Takahashi, S Koga, Y Nakano, Y Shintani, H Hirabayashi, A Matsumura, K Iuchi, K Ito, Y Kishimoto, A Tsuboi, K Ikegame, N Hosen, Y Oka, H Ogawa, H Maeda, S Hayashi, Kawase, I, H Sugiyama
NEOPLASMA Vol. 51 No. 1 p. 17-20 2004 Research paper (scientific journal)
WT1 peptide-based immunotherapy for patients with lung cancer: Report of two cases
A Tsuboi, Y Oka, T Osaki, T Kumagai, Tachibana, I, S Hayashi, M Murakami, H Nakajima, OA Elisseeva, W Fei, T Masuda, M Yasukawa, Y Oji, M Kawakami, N Hosen, K Ikegame, S Yoshihara, K Udaka, S Nakatsuka, K Aozasa, L Kawase, H Sugiyama
MICROBIOLOGY AND IMMUNOLOGY Vol. 48 No. 3 p. 175-184 2004 Research paper (scientific journal)
Monitoring minimal residual disease in leukemia using real-time quantitative polymerase chain reaction for Wilms tumor gene (WT1).
Hiroya Tamaki, Machiko Mishima, Manabu Kawakami, Akihiro Tsuboi, Eui Ho Kim, Naoki Hosen, Kazuhiro Ikegame, Masaki Murakami, Tatsuya Fujioka, Tomoki Masuda, Yuki Taniguchi, Sumiyuki Nishida, Kazuoki Osumi, Toshihiro Soma, Yusuke Oji, Yoshihiro Oka, Ichiro Kawase, Haruo Sugiyama, Hiroyasu Ogawa
International journal of hematology Vol. 78 No. 4 p. 349-56 2003/11 Research paper (scientific journal)
Successful engraftment of HLA-haploidentical related transplants using nonmyeloablative conditioning with fludarabine, busulfan and anti-T-lymphocyte globulin
H Tamaki, K Ikegame, M Kawakami, T Fujioka, A Tsuboi, Y Oji, Y Oka, H Sugiyama, Kawase, I, H Ogawa
LEUKEMIA Vol. 17 No. 10 p. 2052-2054 2003/10
乳癌において発現されるWT1遺伝子は変異のない野生型である
清遠 英司, 尾路 祐介, 三好 康雄, 中野 陽子, 保仙 直毅, 野口 眞三郎, 杉山 治夫
日本癌学会総会記事 Vol. 62回 p. 477-477 2003/08
Publisher: (一社)日本癌学会Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma
Y Oji, H Yamamoto, M Nomura, Y Nakano, A Ikeba, S Nakatsuka, S Abeno, E Kiyotoh, T Jomgeow, M Sekimoto, R Nezu, Y Yoshikawa, Y Inoue, N Hosen, M Kawakami, A Tsuboi, Y Oka, H Ogawa, S Souda, K Aozasa, M Monden, H Sugiyama
CANCER SCIENCE Vol. 94 No. 8 p. 712-717 2003/08 Research paper (scientific journal)
Overexpression of the Wilms' tumor gene WT1 in primary thyroid cancer
Y Oji, Y Miyoshi, S Koga, Y Nakano, A Ando, S Nakatsuka, A Ikeba, E Takahashi, N Sakaguchi, A Yokota, N Hosen, K Ikegame, M Kawakami, A Tsuboi, Y Oka, H Ogawa, K Aozasa, S Noguchi, H Sugiyama
CANCER SCIENCE Vol. 94 No. 7 p. 606-611 2003/07 Research paper (scientific journal)
Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis
Y Oka, A Tsuboi, M Murakami, M Hirai, N Tominaga, H Nakajima, OA Elisseeva, T Masuda, A Nakano, M Kawakami, Y Oji, K Ikegame, N Hosen, K Udaka, M Yasukawa, H Ogawa, L Kawase, H Sugiyama
INTERNATIONAL JOURNAL OF HEMATOLOGY Vol. 78 No. 1 p. 56-61 2003/07 Research paper (scientific journal)
Successful treatment of bcr/abl-positive acute mixed lineage leukemia by unmanipulated bone marrow transplantation from an HLA-haploidentical (3-antigen-mismatched) cousin
K Ikegame, C Mukouchi, A Kunitomi, Y Konaka, M Kawakami, S Nishida, Y Taniguchi, T Fujioka, T Masuda, M Murakami, N Hosen, EH Kim, A Tsuboi, Y Oji, Y Oka, H Sugiyama, Kawase, I, H Ogawa
BONE MARROW TRANSPLANTATION Vol. 31 No. 12 p. 1165-1168 2003/06 Research paper (scientific journal)
Overexpression of the Wilms tumor gene WT1 in head and neck squamous cell carcinoma
Y Oji, H Inohara, M Nakazawa, Y Nakano, S Akahani, S Nakatsuka, S Koga, A Ikeba, S Abeno, Y Honjo, Y Yamamoto, S Iwai, K Yoshida, Y Oka, H Ogawa, J Yoshida, K Aozasa, T Kubo, H Sugiyama
CANCER SCIENCE Vol. 94 No. 6 p. 523-529 2003/06 Research paper (scientific journal)
The lck promoter-driven expression of the Wilms tumor gene WT1 blocks intrathymic differentiation of T-lineage cells
H Li, Y Oka, A Tsuboi, T Yamagami, T Miyazaki, S Yusa, K Kawasaki, Y Kishimoto, M Asada, H Nakajima, K Kanato, S Nishida, T Masuda, M Murakami, N Hosen, M Kawakami, H Ogawa, F Melchers, Kawase, I, Y Oji, H Sugiyama
INTERNATIONAL JOURNAL OF HEMATOLOGY Vol. 77 No. 5 p. 463-470 2003/06 Research paper (scientific journal)
The effect on the proliferation and apoptosis of alloreactive T cells of cell dose in a murine MHC-mismatched hematopoietic cell transplantation model
T Fujioka, Y Taniguchi, T Masuda, S Nishida, K Ikegame, M Kawakami, A Tsuboi, N Hosen, M Murakami, Y Oji, Y Oka, H Sugiyama, Kawase, I, H Ogawa
TRANSPLANT IMMUNOLOGY Vol. 11 No. 2 p. 187-195 2003/04 Research paper (scientific journal)
Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomas
T Ueda, Y Oji, N Naka, Y Nakano, E Takahashi, S Koga, M Asada, A Ikeba, S Nakatsuka, S Abeno, N Hosen, Y Tomita, K Aozasa, N Tamai, A Myoui, H Yoshikawa, H Sugiyama
CANCER SCIENCE Vol. 94 No. 3 p. 271-276 2003/03 Research paper (scientific journal)
The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia
H Ogawa, H Tamaki, K Ikegame, T Soma, M Kawakami, A Tsuboi, EH Kim, N Hosen, M Murakami, T Fujioka, T Masuda, Y Taniguchi, S Nishida, Y Oji, Y Oka, H Sugiyama
BLOOD Vol. 101 No. 5 p. 1698-1704 2003/03 Research paper (scientific journal)
Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues
A Tsuboi, Y Oka, K Udaka, M Murakami, T Masuda, A Nakano, H Nakajima, M Yasukawa, A Hiraki, Y Oji, M Kawakami, N Hosen, T Fujioka, F Wu, Y Taniguchi, S Nishida, M Asada, H Ogawa, Kawase, I, H Sugiyama
CANCER IMMUNOLOGY IMMUNOTHERAPY Vol. 51 No. 11-12 p. 614-620 2002/12 Research paper (scientific journal)
WT1遺伝子の甲状腺癌における過剰発現
浅田 桃太郎, 尾路 祐介, 三好 康雄, 中塚 伸一, 中野 陽子, 岡 芳弘, 小川 啓恭, 青笹 克之, 野口 眞三郎, 杉山 治夫
日本癌学会総会記事 Vol. 61回 p. 245-245 2002/10
Publisher: (一社)日本癌学会甲状腺癌において高発現するWT1遺伝子の突然変異に関する解析
古賀 聖子, 尾路 祐介, 三好 康雄, 中野 陽子, 野口 眞三郎, 杉山 治夫
日本癌学会総会記事 Vol. 61回 p. 245-245 2002/10
Publisher: (一社)日本癌学会Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers
Y Oji, S Miyoshi, H Maeda, S Hayashi, H Tamaki, SI Nakatsuka, M Yao, E Takahashi, Y Nakano, H Hirabayashi, Y Shintani, Y Oka, A Tsuboi, N Hosen, M Asada, T Fujioka, M Murakami, K Kanato, M Motomura, EH Kim, M Kawakami, K Ikegame, H Ogawa, K Aozasa, Kawase, I, H Sugiyama
INTERNATIONAL JOURNAL OF CANCER Vol. 100 No. 3 p. 297-303 2002/07 Research paper (scientific journal)
Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation
H Ogawa, T Soma, N Hosen, T Tatekawa, A Tsuboi, Y Oji, H Tamaki, M Kawakami, K Ikegame, M Murakami, T Fujioka, EH Kim, Y Oka, H Sugiyama
TRANSPLANTATION Vol. 74 No. 2 p. 236-243 2002/07 Research paper (scientific journal)
Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies
OA Elisseeva, Y Oka, A Tsuboi, K Ogata, F Wu, EH Kim, T Soma, H Tamaki, M Kawakami, Y Oji, N Hosen, T Kubota, M Nakagawa, T Yamagami, A Hiraoka, M Tsukaguchi, K Udaka, H Ogawa, T Kishimoto, T Nomura, H Sugiyama
BLOOD Vol. 99 No. 9 p. 3272-3279 2002/05 Research paper (scientific journal)
Very low frequencies of human normal CD34(+) haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells
N Hosen, Y Sonoda, Y Oji, T Kimura, H Minamiguchi, H Tamaki, M Kawakami, M Asada, K Kanato, M Motomura, M Murakami, T Fujioka, T Masuda, EH Kim, A Tsuboi, Y Oka, T Soma, H Ogawa, H Sugiyama
BRITISH JOURNAL OF HAEMATOLOGY Vol. 116 No. 2 p. 409-420 2002/02 Research paper (scientific journal)
固形癌の腫瘍マーカーとしてのWT1遺伝子
尾路 祐介, 三好 新一郎, 林 清二, 玉置 広哉, 岡 芳弘, 坪井 昭博, 小川 啓恭, 杉山 治夫
日本分子腫瘍マーカー研究会誌 Vol. 15 p. 37-37 2000
Publisher: Japanese Society for Molecular Tumor Marker ResearchThe Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes
H Tamaki, H Ogawa, K Ohyashiki, JH Ohyashiki, H Iwama, K Inoue, T Soma, Y Oka, T Tatekawa, Y Oji, A Tsuboi, EH Kim, M Kawakami, K Fuchigami, M Tomonaga, K Toyama, K Aozasa, T Kishimoto, H Sugiyama
LEUKEMIA Vol. 13 No. 3 p. 393-399 1999/03 Research paper (scientific journal)
Suppression of Wilms' tumor gene (WT1) expression induces G(2)/M arrest in leukemic cells
T Yamagami, H Ogawa, H Tamaki, Y Oji, T Soma, Y Oka, T Tatekawa, A Tsuboi, EH Kim, T Akiyama, H Sugiyama
LEUKEMIA RESEARCH Vol. 22 No. 4 p. 383-384 1998/04
High incidence of chemotherapy-induced acral erythema in female patients with non-Hodgkin's lymphoma treated with the VACOP-B regimen
H Ogawa, H Sugiyama, Y Tani, T Soma, T Yamagami, T Tatekawa, Y Oji, T Kubota, T Kimura, K Inoue, M Nakagawa, K Sasaki, T Matsunashi, S Miyake, T Kishimoto
LEUKEMIA & LYMPHOMA Vol. 29 No. 1-2 p. 171-+ 1998/03 Research paper (scientific journal)
Secondary acute monocytic leukemia occurring during the treatment of a testicular germ cell tumor - A case report and review of the literature
N Nonomura, N Murosaki, Y Kojima, N Kondoh, T Seguchi, Y Takeda, Y Oji, H Ogawa, H Sugiyama, T Miki, A Okuyama
UROLOGIA INTERNATIONALIS Vol. 58 No. 4 p. 239-242 1997 Research paper (scientific journal)
Septicemia associated with hematopoietic disorders and its features according to respective primary disorders
Yokota T, Teshima H, Okajima Y, Tsuboi A, Oji Y, Karasuno T, Hiraoka A, Masaoka T
Journal of Infectious Deseases (Japanese) 1996/02 Research paper (scientific journal)
The monitoring of cytomegalovirus antigenemia and arterial oxygen saturation for the early detection of cytomegalovirus pneumonia
Tatekawa T, Yokota T, Oji Y, Moriyama Y, Tominaga N, Teshima H, Hiraoka A, Nakamura H, Shibata H, Minamishima Y
Clinical Hematology (Japanese) 1994/11 Research paper (scientific journal)
Treatment of graft failure after bone marrow transplantation.
Yokota T, Tsuboi A, Okajima Y, Oji Y, Moriyama Y, Tatekawa T, Karasuno T, Tominanga N, Tejima H, Hiraoka A, Nakamura H, Masaoka T
Leukemia Research Vol. 18 No. 11 p. 875-876 1994/04 Research paper (scientific journal)
TCF1レポーターマウスを活用した腫瘍局所と所属リンパ節に存在する癌抗原特異的CD8+ T細胞の分類と解析
永田暁教, 藤木文博, 森本創世子, 中田潤, 西田純幸, 西田純幸, 中島博子, 橋井佳子, 橋井佳子, 坪井昭博, 岡芳弘, 尾路祐介, 杉山治夫
日本がん免疫学会総会プログラム・抄録集 Vol. 27th 2023
Long-term outcome of a cocktail Wilms’ tumor 1 (WT1) vaccination using two HLA class I peptides and one class II peptide against recurrent malignant gliomas
香川尚己, 尾路祐介, 平山龍一, 木嶋教行, 岡芳弘, 杉山治夫, 貴島晴彦
日本脳腫瘍学会学術集会プログラム・抄録集 Vol. 41st 2023
Immune monitoring of malignant glioma patients treated with WT1 Trio peptide-based cancer immunotherapy
Mizuki Kanegae, Naoki Kagawa, Noriyuki Kijima, Ryuichi Hirayama, Haruka Shimokado, Sumiyuki Nishida, Naoki Hosen, Akihiro Tsuboi, Yoshihiro Oka, Haruo Sugiyama, Haruhiko Kishima, Yusuke Oji
CANCER SCIENCE Vol. 113 p. 524-524 2022/02 Research paper, summary (international conference)
WT1蛋白を標的とした小児固形腫瘍に対するがん免疫療法:予後と免疫学的解析
橋井佳子, 橋井佳子, 細谷要介, 岡芳弘, 尾路祐介, 中島博子, 中田潤, 藤木文博, 森本創世子, SHOUQ Alzaaqi, 鐘ヶ江瑞稀, 西田純幸, 大薗恵一, 坪井昭博, 杉山治夫
日本がん免疫学会総会プログラム・抄録集 Vol. 26th 2022
悪性神経膠腫に対するWT1ペプチドワクチン免疫療法WT1 Trioの免疫モニタリング
鐘ヶ江 瑞稀, 池島 彩香, 香川 尚己, 木嶋 教行, 平山 龍一, 下門 遥, 西田 純幸, 保仙 直毅, 坪井 昭博, 岡 芳弘, 杉山 治夫, 貴島 晴彦, 尾路 祐介
日本癌学会総会記事 Vol. 80回 p. [P12-6] 2021/09
Publisher: (一社)日本癌学会WT1-235ペプチドワクチンを施行された肉腫患者におけるWT1-235 IgMおよびIgG抗体
アルザキ・ショーク, 王谷 英達, 鐘ヶ江 瑞稀, 下門 遥, 西田 純幸, 保仙 直毅, 坪井 昭博, 岡 芳弘, 杉山 治夫, 尾路 祐介
日本癌学会総会記事 Vol. 80回 p. [P12-6] 2021/09
Publisher: (一社)日本癌学会WT1-targeteing immunotherapy after allogeneic HSCT in children with refractory acute leukemias(和訳中)
橋井 佳子, 岡 芳弘, 坂田 尚己, 渡辺 新, 尾路 祐介, 保仙 直毅, 山本 紘司, 服部 聡, 中島 博子, 中田 潤, 藤木 文博, 森本 創世子, Alzaaqi Shouq, 池島 彩香, 西田 純幸, 大薗 恵一, 坪井 昭博, 杉山 治夫
日本血液学会学術集会 Vol. 83回 p. OS1-5 2021/09
Publisher: (一社)日本血液学会WT1ヘルパーペプチド併用WT1ペプチドワクチン投与患者における異なる2つのWT1-tetramer+CD8+T細胞集団の同定
藤木 文博, 坪井 昭博, 森本 創世子, 橋本 直哉, 稲留 美希, 中島 博子, 中田 潤, 西田 純幸, 岡 芳弘, 尾路 祐介, 杉山 治夫
日本がん免疫学会総会プログラム・抄録集 Vol. 25回 p. 175-175 2021/05
Publisher: 日本がん免疫学会Imaging assessment of tumor response in the era of immunotherapy
Jun Nakata, Kayako Isohashi, Yoshihiro Oka, Hiroko Nakajima, Soyoko Morimoto, Fumihiro Fujiki, Yusuke Oji, Akihiro Tsuboi, Atsushi Kumanogoh, Naoya Hashimoto, Jun Hatazawa, Haruo Sugiyama
Diagnostics Vol. 11 No. 6 2021 Book review, literature introduction, etc.
再発悪性神経膠腫に対するWT1カクテルワクチン療法(WT1 trio)
香川尚己, 尾路祐介, 坪井昭博, 平山龍一, 木嶋教行, 木下学, 岡芳弘, 杉山治夫, 貴島晴彦
Brain Tumor Pathology (Web) Vol. 37 No. Supplement 2020
WT1ペプチドワクチン癌免疫療法のバイオマーカーとしてのWT1ペプチドIgG抗体
尾路 祐介, 西田 純幸, 今西 凛, 池島 彩香, 鐘ヶ江 瑞希, Alzaaqi Shouq, 中田 潤, 保仙 直毅, 坪井 昭博, 岡 芳弘, 杉山 治夫
日本分子腫瘍マーカー研究会誌 Vol. 35 p. 39-40 2019/12
Publisher: 日本分子腫瘍マーカー研究会癌免疫 脳腫瘍患者におけるWT1ヘルパーペプチド併用WT1ペプチドワクチン療法の免疫モニタリング解析
森本 創世子, 藤木 文博, 近藤 健太, 中島 博子, 西田 純幸, 中田 潤, 保仙 直毅, 坪井 昭博, 岡 芳弘, 尾路 祐介, 杉山 治夫
日本臨床免疫学会総会プログラム・抄録集 Vol. 47回 p. 85-85 2019/10
Publisher: 日本臨床免疫学会WT1ペプチドワクチンを施行されたMPN患者におけるJAK2 V617F変異mRNAの検出(Detection of JAK2 V617F mRNA in a MPN patient treated with WT1 peptide-based immunotherapy)
大崎 瑞希, 池田 真優, 八木 健斗, 中田 潤, 西田 純幸, 保仙 直毅, 坪井 昭博, 岡 芳弘, 杉山 治夫, 尾路 祐介
日本癌学会総会記事 Vol. 78回 p. P-2320 2019/09
Publisher: (一社)日本癌学会WT1ペプチドワクチンを施行されたMPN患者におけるJAK2 V617F変異mRNAの検出(Detection of JAK2 V617F mRNA in a MPN patient treated with WT1 peptide-based immunotherapy)
大崎 瑞希, 池田 真優, 八木 健斗, 中田 潤, 西田 純幸, 保仙 直毅, 坪井 昭博, 岡 芳弘, 杉山 治夫, 尾路 祐介
日本癌学会総会記事 Vol. 78回 p. P-2320 2019/09
Publisher: 日本癌学会WT1ヘルパーペプチドの併用ワクチン療法は腫瘍内へのWT1特異的CTLの浸潤を増強する
中田 潤, 中島 博子, 森本 創世子, 藤木 文博, 長谷川 加奈, 保仙 直毅, 坪井 昭博, 尾路 祐介, 岡 芳弘, 熊ノ郷 淳, 杉山 治夫
日本がん免疫学会総会プログラム・抄録集 Vol. 23回 p. 161-161 2019/07
Publisher: 日本がん免疫学会進行卵巣癌に対するWT1を標的とした癌ワクチンに関する臨床研究(Clinical Study of the Cancer Vaccine targeting WT1 for Advanced Ovarian Cancer)
西田 純幸, 白方 俊章, 森本 創世子, 榎本 隆之, 吉野 潔, 冨松 拓治, 藤木 文博, 尾路 祐介, 上田 豊, 坪井 昭博, 森田 智視, 岡 芳弘, 熊ノ郷 淳, 木村 正, 杉山 治夫
日本がん免疫学会総会プログラム・抄録集 Vol. 23回 p. 159-159 2019/07
Publisher: 日本がん免疫学会【血液領域における免疫療法と抗体医薬-最近の展開】急性骨髄性白血病に対するWT1ペプチドワクチンの有用性
中田 潤, 中江 吉希, 川上 学, 坪井 昭博, 森本 創世子, 中島 博子, 橋井 佳子, 藤木 文博, 西田 純幸, 長谷川 加奈, 保仙 毅, 尾路 祐介, 岡 芳弘, 杉山 治夫
血液内科 Vol. 79 No. 1 p. 19-25 2019/07
Publisher: (有)科学評論社再発神経膠腫に対する3種混合WT1ペプチドワクチン療法(WT1 trio)の安全性と有効性
香川尚己, 尾路祐介, 坪井昭博, 平山龍一, 木嶋教行, 木下学, 岡芳弘, 杉山治夫, 貴島晴彦
日本脳腫瘍学会プログラム・抄録集 Vol. 37th 2019
癌抗原特異的T細胞受容体のfunctional avidityを効率よく正確に評価できるplatform細胞の作製
森本 創世子, 藤木 文博, 近藤 健太, 中島 博子, 小林 善貴, 稲留 美希, 青山 奈央, 西田 優也, 坪井 昭博, 岡 芳弘, 西田 純幸, 中田 潤, 保仙 直毅, 尾路 祐介, 杉山 治夫
日本臨床免疫学会総会プログラム・抄録集 Vol. 46回 p. 102-102 2018/11
Publisher: 日本臨床免疫学会癌抗原特異的T細胞受容体のfunctional avidityを効率よく正確に評価できるplatform細胞の作製
森本 創世子, 藤木 文博, 近藤 健太, 中島 博子, 小林 善貴, 稲留 美希, 青山 奈央, 西田 優也, 坪井 昭博, 岡 芳弘, 西田 純幸, 中田 潤, 保仙 直毅, 尾路 祐介, 杉山 治夫
日本臨床免疫学会総会プログラム・抄録集 Vol. 46回 p. 133-133 2018/11
Publisher: 日本臨床免疫学会急性骨髄性白血病に対するWT1ワクチン療法(WT1 vaccine therapy against acute myeloid leukemia)
中田 潤, 中江 吉希, 中島 博子, 水谷 陽, 森本 創世子, 藤木 文博, 西田 純幸, 保仙 直毅, 坪井 昭博, 尾路 祐介, 岡 芳宏, 川上 学, 熊ノ郷 敦, 杉山 治夫
臨床血液 Vol. 59 No. 9 p. 1686-1686 2018/09
Publisher: (一社)日本血液学会-東京事務局癌抗原特異的T細胞受容体のfunctional avidityを効率よく正確に評価できるplatform細胞の作製
森本 創世子, 藤木 文博, 近藤 健太, 中島 博子, 小林 善貴, 稲留 美希, 青山 奈央, 西田 優也, 西田 純幸, 中田 潤, 保仙 直毅, 坪井 昭博, 岡 芳弘, 尾路 祐介, 杉山 治夫
日本がん免疫学会総会プログラム・抄録集 Vol. 22回 p. 100-100 2018/07
Publisher: 日本がん免疫学会希少癌に対するWT1ペプチドワクチン免疫療法WT1 Trioの免疫モニタリング
尾路 祐介, 岩井 美樹, 林 紗恵, 香川 尚己, 有田 英之, 新谷 康, 武田 吉人, 森井 英一, 濱田 健一郎, 島津 研三, 鈴木 基之, 中島 博子, 藤木 文博, 今西 凜, 中田 潤, 西田 純幸, 保仙 直毅, 坪井 昭博, 岡 芳博, 杉山 治夫
日本がん免疫学会総会プログラム・抄録集 Vol. 22回 p. 150-150 2018/07
Publisher: 日本がん免疫学会急性骨髄性白血病に対するWT1ペプチド免疫療法
中田 潤, 西田 純幸, 保仙 直毅, 坪井 昭博, 尾路 祐介, 岡 芳弘, 杉山 治夫, 川上 学, 中江 吉希
臨床血液 Vol. 59 No. 2 p. 233-233 2018/02
Publisher: (一社)日本血液学会-東京事務局抗体医薬開発の新しい戦略 多発性骨髄腫における高度な小胞体ストレス下で発現するCD98は特異的抗体療法の標的となる
長谷川 加奈, 尾路 祐介, 熊ノ郷 淳, 杉山 治夫, 保仙 直毅
日本癌学会総会記事 Vol. 76回 p. S11-5 2017/09
Publisher: (一社)日本癌学会活性化インテグリンβ7を標的とした多発性骨髄腫特異的CAR-T細胞療法
保仙 直毅, 長谷川 加奈, 尾路 祐介, 熊ノ郷 淳, 杉山 治夫
日本癌学会総会記事 Vol. 76回 p. E-3004 2017/09
Publisher: (一社)日本癌学会膵臓癌患者におけるウィルムス腫瘍遺伝子(WT1)発現の臨床的意義
金井 友哉, 伊藤 善翔, 尾路 祐介, 須賀 万智, 西田 純幸, 高倉 一樹, 梶原 幹生, 藤岡 秀一, 三澤 健之, 秋葉 直志, 柳澤 裕之, 猿田 雅之, 岡本 正人, 杉山 治夫, 小井戸 薫雄
日本消化器病学会雑誌 Vol. 114 No. 臨増大会 p. A864-A864 2017/09
Publisher: (一財)日本消化器病学会切除不能進行膵癌に対するゲムシタビン併用HLA拘束性WT1ペプチドワクチン療法で誘導されたWT1特異的CTLの免疫学的機能解析
森本 創世子, 西田 純幸, 小井戸 薫雄, 江川 新一, 石川 剛, 石井 淳, 菅野 良秀, 柳本 泰明, 江口 英利, 中田 潤, 保仙 直毅, 坪井 昭博, 長谷川 加奈, 中島 博子, 藤木 文博, 尾路 祐介, 熊ノ郷 淳, 岡 芳弘, 杉山 治夫
日本がん免疫学会総会プログラム・抄録集 Vol. 21回 p. 104-104 2017/06
Publisher: 日本がん免疫学会Regulation of Stemness in Carcinoma Cells
Jijun Hao, Juli Unternaehrer, Xiaojiang Cui, Ninghui Cheng, Yusuke Oji
STEM CELLS INTERNATIONAL 2017 Other
Identification of New Multiple Myeloma-Specific Cell Surface Antigens As Immunotherapeutic Targets
Naoki Hosen, Kana Hasegawa, Yasutaka Aoyama, Hiroyoshi Ichihara, Atsuko Mugitani, Takafumi Nakao, Masahiro Manabe, Yusuke Oji, Haruo Sugiyama
BLOOD Vol. 128 No. 22 2016/12 Research paper, summary (international conference)
多発性骨髄腫特異的抗原の同定とそれを標的とした免疫療法の開発
保仙 直毅, 長谷川 加奈, 尾路 祐介, 熊ノ郷 淳, 杉山 治夫
日本癌学会総会記事 Vol. 75回 p. E-3055 2016/10
Publisher: (一社)日本癌学会CD43分子上の糖鎖修飾が白血病に腫瘍抗原特異的CTLに対する抵抗性をもたらす
長谷川 加奈, 中島 博子, 西田 純幸, 坪井 昭博, 岡 芳弘, 尾路 祐介, 熊ノ郷 淳, 杉山 治夫, 保仙 直毅
日本癌学会総会記事 Vol. 75回 p. J-3065 2016/10
Publisher: 日本癌学会膠芽腫におけるWT1ワクチン治療の長期免疫維持と注射局所および血中の免疫反応
泉本 修一, 友金 祐介, 清原 英司, 尾路 祐介, 森井 英一, 加藤 天美
Brain Tumor Pathology Vol. 33 No. Suppl. p. 092-092 2016/05
Publisher: 日本脳腫瘍病理学会がん免疫療法 再発ハイリスク同種造血幹細胞移植後患者に対するWT1ペプチドワクチン臨床試験
保仙 直毅, 前田 哲生, 森本 創世子, 高島 聡士, 中田 潤, 西田 純幸, 坪井 昭博, 尾路 祐介, 岡 芳弘, 熊ノ郷 淳, 杉山 治夫
MHC: Major Histocompatibility Complex Vol. 23 No. 1 p. 71-71 2016/04
Publisher: 日本組織適合性学会Promotion of homologous recombination-mediated DNA damage repair by Wilmls' tumor gene WT1
Vol. 50 No. 4 p. 370-380 2015/12
Publisher: 放射線生物研究会WT1ペプチドIgG抗体 グリオブラストーマに対するWT1ペプチドワクチンの治療反応性予測マーカー
岩井 美樹, 尾路 祐介, 村上 由依, 橋本 直哉, 坪井 昭博, 保仙 直毅, 西田 純幸, 中田 潤, 中島 博子, 岡 芳弘, 吉峰 俊樹, 杉山 治夫
日本癌学会総会記事 Vol. 74回 p. J-1171 2015/10
Publisher: 日本癌学会Enhancement of efficacy of Wilms’ Tumor Gene WT1 product-derived peptide cancer vaccine by co-administration with immunopotentiating agents: Lessons from mouse models
Hiroko Nakajima, Yoshihiro Oka, Akihiro Tsuboi, Fumihiro Fujiki, Naoya Tatsumi, Naoki Hosen, Yusuke Oji, Haruo Sugiyama
Inflammation and Immunity in Cancer p. 165-183 2015/01/01
Publisher: Springer JapanClinical Phase II Study of WT1 Peptide Vaccination in Pediatric Leukemia Patients after Stem Cell Transplantation and Analysis of Immunological Monitoring
Yoshiko Hashii, Yoshihiro Oka, Takako Miyamura, Yusuke Oji, Naoki Hosen, Akihiro Tsuboi, Haruo Sugiyama, Keiichi Ozono
BLOOD Vol. 124 No. 21 2014/12 Research paper, summary (international conference)
WT1 PEPTIDE VACCINATION AGAINST GLIOMAS; COMBINATION WITH TEMOZOLOMIDE, BIOMARKERS AND IMMUNOLOGICAL RESPONSE
Naoya Hashimoto, Yasuyoshi Chiba, Noriyuki Kijima, Hideyuki Arita, Manabu Kinoshita, Naoki Kagawa, Akihiro Tsuboi, Yoshihiro Oka, Yusuke Oji, Haruo Sugiyama, Toshiki Yoshimine
NEURO-ONCOLOGY Vol. 16 2014/11 Research paper, summary (international conference)
当院における胸部悪性腫瘍に対するWT1ペプチド免疫療法
大塚 倫之, 武田 吉人, 保仙 直毅, 岡 芳弘, 南 俊行, 平田 陽彦, 井上 幸治, 長友 泉, 木田 博, 坪井 昭博, 尾路 祐介, 木島 貴志, 杉山 治夫, 熊ノ郷 淳
肺癌 Vol. 54 No. 5 p. 562-562 2014/10
Publisher: (NPO)日本肺癌学会初発膠芽腫に対するテモゾロミド併用WT1ワクチン療法 第I相臨床試験(WT1 peptide-based immunotharapy combined with Temozolomide for patients with newly diagnosed glioblastoma)
坪井 昭博, 橋本 直哉, 香川 尚己, 泉本 修一, 岡 芳弘, 尾路 祐介, 保仙 直毅, 西田 純幸, 森本 創世子, 吉峰 俊樹, 杉山 治夫
日本癌学会総会記事 Vol. 73回 p. P-1224 2014/09
Publisher: 日本癌学会再発悪性神経膠腫を対象としたWT1キラーペプチドとWT1ヘルパーペプチドを用いた免疫療法 第I相試験
坪井 昭博, 橋本 直哉, 岡 芳弘, 森本 創世子, 尾路 祐介, 保仙 直毅, 西田 純幸, 中田 潤, 中江 吉希, 中島 博子, 吉峰 俊樹, 杉山 治夫
日本がん免疫学会総会プログラム・抄録集 Vol. 18回 p. 73-73 2014/06
Publisher: 日本がん免疫学会再発小児悪性神経膠腫に対するWT1ペプチドワクチン療法の治療成績
香川尚己, 橋井佳子, 橋本直哉, 千葉泰良, 平山龍一, 坪井昭博, 尾路祐介, 岡芳弘, 杉山治夫, 吉峰俊樹
小児の脳神経 Vol. 39 No. 1 p. 65-65 2014/04/30
Publisher: (一社)日本小児神経外科学会A DIRECT COMPARISON OF RESPONSE ASSESSMENTS IN A PHASE II CLINICAL TRIAL OF WT1 PEPTIDE VACCINATION; MACDONALD, RECIST AND RANO CRITERIA
Naoya Hashimoto, Yasuyoshi Chiba, Akihiro Tsuboi, Manabu Kinoshita, Ryuichi Hirayama, Naoki Kagawa, Yoshihiro Oka, Yusuke Oji, Haruo Sugiyama, Toshiki Yoshimine
NEURO-ONCOLOGY Vol. 15 p. 111-111 2013/11 Research paper, summary (international conference)
HLA class II拘束性WT1特異的T Cell Receptor遺伝子導入によるヘルパー活性とキラー活性を有するCD4+T細胞の作製
藤木 文博, 林 ユウ宏, 勝原 晶子, 岡 芳弘, 坪井 昭博, 青山 奈央, 谷井 里江, 中島 博子, 森本 創世子, 保仙 直毅, 尾路 祐介, 熊ノ郷 淳, 杉山 治夫
日本臨床免疫学会会誌 Vol. 36 No. 5 p. 337-337 2013/10
Publisher: (一社)日本臨床免疫学会初発膠芽腫に対するテモゾロミド併用WT1ワクチン療法 第I相臨床試験(WT1 peptide-based immunotharapy in combination with Temozolomide for patients with newly diagnosed glioblastoma)
坪井 昭博, 橋本 直哉, 香川 尚己, 千葉 泰良, 泉本 修一, 岡 芳弘, 尾路 祐介, 保仙 直毅, 西田 純幸, 森本 創世子, 吉峰 俊樹, 杉山 治夫
日本癌学会総会記事 Vol. 72回 p. 365-365 2013/10
Publisher: 日本癌学会HLA-DPB1*05:01拘束性WT1特異的TCRを導入されたCD4+T細胞はヘルパー活性と細胞傷害活性を有する
藤木 文博, 林 兪宏, 勝原 晶子, 岡 芳弘, 坪井 昭博, 青山 奈央, 谷井 里江, 中島 博子, 森本 創世子, 保仙 直毅, 西田 純幸, 尾路 祐介, 熊ノ郷 淳, 杉山 治夫
日本がん免疫学会総会プログラム・抄録集 Vol. 17回 p. 85-85 2013/07
Publisher: 日本がん免疫学会当院における胸部悪性腫瘍に対するWT1ペプチド免疫療法
武田 吉人, 岡 芳弘, 高橋 良, 保仙 直毅, 平田 陽彦, 河面 聡, 井上 幸治, 長友 泉, 木田 博, 木島 貴志, 大崎 匡, 立花 功, 熊ノ郷 淳, 川瀬 一郎, 尾路 祐介, 杉山 治夫
肺癌 Vol. 52 No. 7 p. 1076-1076 2012/12
Publisher: (NPO)日本肺癌学会WT1ペプチドワクチンによる再発抑制効果を期待した小児悪性骨・軟部腫瘍対象多施設共同臨床試験
橋井 佳子, 坪井 昭博, 尾路 祐介, 中島 博子, 岡 芳弘, 岩城 拓磨, 岩瀬 孝志, 細谷 要介, 真部 淳, 辻 尚子, 湯坐 有希, 杉山 治夫, 大薗 恵一
日本小児血液・がん学会学術集会・日本小児がん看護学会・公益財団法人がんの子どもを守る会公開シンポジウムプログラム総会号 Vol. 54回・10回・17回 p. 426-426 2012/11
Publisher: (NPO)日本小児血液・がん学会・(NPO)日本小児がん看護学会・(公財)がんの子供を守る会WT1 PEPTIDE VACCINATION FOR NEWLY DIAGNOSED GLIOBLASTOMAS; PHASE I CLINICAL TRIAL OF COMBINATION WITH TEMOZOLOMIDE
Naoya Hashimoto, Akihiro Tsuboi, Yasuyoshi Chiba, Noriyuki Kijima, Yoshihiro Oka, Yusuke Oji, Manabu Kinoshita, Naoki Kagawa, Toshiki Yoshimine, Haruo Sugiyama
NEURO-ONCOLOGY Vol. 14 p. 45-46 2012/10 Research paper, summary (international conference)
カバーメークとがんワクチン治療患者のQOL
分田 貴子, 西田 純幸, 坪井 昭博, 保仙 直毅, 梅田 智恵, 種村 篤, 片山 一朗, 尾路 祐介, 岡 芳弘, 杉山 治夫, 平家 勇司
日本癌治療学会誌 Vol. 47 No. 3 p. 1046-1046 2012/10
Publisher: (一社)日本癌治療学会再発ハイリスク同種造血幹細胞移植後患者に対するWT1ペプチドワクチン第1相臨床試験
保仙 直毅, 前田 哲生, 福島 健太郎, 森本 創世子, 中田 潤, 中江 吉希, 西田 純幸, 坪井 昭博, 近藤 忠一, 門脇 則光, 日野 雅之, 尾路 祐介, 岡 芳弘, 熊ノ郷 淳, 金倉 譲, 杉山 治夫
臨床血液 Vol. 53 No. 9 p. 1051-1051 2012/09
Publisher: (一社)日本血液学会-東京事務局治療抵抗性婦人科悪性腫瘍におけるWT1ペプチドワクチン第II相臨床試験(Phase II trial of WT1 peptide vaccine to gynecologic malignancies which are resistant to conventional therapies)
森本 晶子, 上田 豊, 宮武 崇, 榎本 隆之, 岡 芳弘, 西田 純幸, 坪井 昭博, 白方 俊章, 尾路 祐介, 森田 智視, 坂本 純一, 杉山 治夫, 木村 正
日本癌学会総会記事 Vol. 71回 p. 145-145 2012/08
Publisher: 日本癌学会がんワクチン治療と患者QOL接種痕に対するカバーメイクの導入(Cancer vaccine therapy and patients' quality of life, Caver-makeup for unsightly skin reactions)
分田 貴子, 西田 純幸, 坪井 昭博, 保仙 直毅, 尾路 祐介, 梅田 智恵, 種村 篤, 片山 一朗, 岡 芳弘, 杉山 治夫, 平家 勇司
日本癌学会総会記事 Vol. 71回 p. 471-471 2012/08
Publisher: 日本癌学会初発悪性神経膠腫を対象としたテモゾロミド併用WT1ペプチドワクチン第I相臨床試験(Phase I clinical trial of WT1 peptide vaccination combined with temozolomide for newly diagnosed malignant glioma)
坪井 昭博, 橋本 直哉, 岡 芳弘, 香川 尚己, 木下 学, 木嶋 教行, 千葉 泰良, 尾路 祐介, 保仙 直毅, 西田 純幸, 吉峰 俊樹, 杉山 治夫
日本癌学会総会記事 Vol. 71回 p. 102-102 2012/08
Publisher: 日本癌学会臨床橋渡し研究の進展 初発悪性神経膠腫を対象としたテモゾロミド併用WT1ペプチドワクチン第I相臨床試験
坪井 昭博, 橋本 直哉, 香川 尚己, 千葉 泰良, 岡 芳弘, 尾路 祐介, 保仙 直毅, 西田 純幸, 吉峰 俊樹, 杉山 治夫
日本がん免疫学会総会プログラム・抄録集 Vol. 16回 p. 55-55 2012/07
Publisher: 日本がん免疫学会WT1ペプチドワクチンを用いた小児固形がんに対する免疫治療
橋井 佳子, 坪井 昭博, 西田 純幸, 尾路 祐介, 岡 芳弘, 杉山 治夫
日本がん免疫学会総会プログラム・抄録集 Vol. 16回 p. 93-93 2012/07
Publisher: 日本がん免疫学会Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease
A. Tsuboi, Y. Oka, T. Kyo, Y. Katayama, O. A. Elisseeva, M. Kawakami, S. Nishida, S. Morimoto, A. Murao, H. Nakajima, N. Hosen, Y. Oji, H. Sugiyama
LEUKEMIA Vol. 26 No. 6 p. 1410-1413 2012/06 Rapid communication, short report, research note, etc. (scientific journal)
WT1 peptide vaccination following allogeneic stem cell transplantation in pediatric leukemic patients with high risk for relapse: successful maintenance of durable remission
Y. Hashii, E. Sato-Miyashita, R. Matsumura, S. Kusuki, H. Yoshida, H. Ohta, N. Hosen, A. Tsuboi, Y. Oji, Y. Oka, H. Sugiyama, K. Ozono
LEUKEMIA Vol. 26 No. 3 p. 530-532 2012/03 Rapid communication, short report, research note, etc. (scientific journal)
WT1ペプチドワクチンとIFN-βの併用投与によるWT1発現白血病細胞に対する拒絶効果の増強
中島 博子, 岡 芳弘, 坪井 昭博, 辰巳 直也, 藤木 文博, 森本 創世子, 保仙 直毅, 白方 俊章, 西田 純幸, 尾路 祐介, 杉山 治夫
臨床血液 Vol. 52 No. 9 p. 1000-1000 2011/09
Publisher: (一社)日本血液学会-東京事務局血液悪性疾患に対する同種造血幹細胞移植後のadjuvant therapyとしてのWT1 peptide vaccinationの検討
前田 哲生, 保仙 直毅, 佐多 弘, 中田 潤, 西田 純幸, 坪井 昭博, 尾路 祐介, 福島 健太郎, 岡 芳弘, 水木 満佐央, 織谷 健司, 杉山 治夫, 金倉 譲
臨床血液 Vol. 52 No. 9 p. 1000-1000 2011/09
Publisher: (一社)日本血液学会-東京事務局IFN-β併用投与によるWT1ペプチドワクチンの腫瘍拒絶効果の増強(WT1 peptide vaccination combined with IFN-β enhances tumor rejection in a mice model)
中島 博子, 岡 芳弘, 坪井 昭博, 辰巳 直也, 藤木 文博, 森本 創世子, 保仙 直毅, 白方 俊章, 西田 純幸, 尾路 祐介, 杉山 治夫
日本癌学会総会記事 Vol. 70回 p. 339-339 2011/09
Publisher: 日本癌学会造血幹細胞移植後患者に対するWT1ワクチン免疫療法
保仙 直毅, 前田 哲生, 山根 孝久, 日野 雅之, 森本 創世子, 原 一真, 中田 潤, 西田 純幸, 坪井 昭博, 尾路 祐介, 岡 芳弘, 金倉 譲, 森田 智視, 坂本 純一, 杉山 治夫
日本がん免疫学会総会プログラム・抄録集 Vol. 15回 p. 88-88 2011/06
Publisher: 日本がん免疫学会悪性腫瘍に対するWT1ペプチドワクチン治療-特に,造血器腫瘍に焦点をあてて-
岡 芳弘, 坪井 昭博, 西田 純幸, 保仙 直毅, 中田 潤, 橋井 佳子, 前田 哲生, 尾路 祐介, 熊ノ郷 淳, 杉山 治夫
臨床血液 Vol. 52 p. 235-242 2011
Long-Term WT1 Peptide Vaccination Over 7 Years for 3 AML Patients with Molecular Relapse
Haruo Sugiyama, Akihiro Tsuboi, Yoshihiro Oka, Taiichi Kyo, Yuuta Katayama, Elisseeva Olga, Manabu Kawakami, Naoki Hosen, Sumiyuki Nishida, Soyoko Morimoto, Ayako Murao, Hiroko Nakajima, Ichiro Kawase, Yusuke Oji, Hiroo Dohy
BLOOD Vol. 116 No. 21 p. 1350-1350 2010/11 Research paper, summary (international conference)
WT1-Targeted Dendritic Cell Vaccination as A Post-Remission Treatment to Prevent Full Relapse In Acute Myeloid Leukemia
Zwi N. Berneman, Ann Van de Velde, Sebastien Anguille, Nathalie Cools, Ann Van Driessche, Katrien Vermeulen, Katrien Pieters, Griet Nijs, Barbara Stein, Evelien L. Smits, Wilfried A. Schroyens, Alain P. Gadisseur, Inge Vrelust, I. Jolanda de Vries, Kristin Ladell, Emma Gostick, David A. Price, Yusuke Oji, Yoshihiro Oka, Haruo Sugiyama, Viggo F. Van Tendeloo
BLOOD Vol. 116 No. 21 p. 12-13 2010/11 Research paper, summary (international conference)
DENDRITIC CELL VACCINATION AS POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA: RESULTS OF A PILOT PHASE I/II CLINICAL TRIAL
S. Anguille, V. Van Tendeloo, A. Van de Velde, A. Van Driessche, K. Vermeulen, K. Pieters, G. Nijs, B. Stein, E. Smits, W. Schroyens, A. Gadisseur, I. Vrelust, P. Jorens, H. Goossens, D. Price, J. De Vries, Y. Oji, Y. Oka, H. Sugiyama, N. Cools, Z. Berneman
EXPERIMENTAL HEMATOLOGY Vol. 38 No. 9 p. S36-S37 2010/09 Research paper, summary (international conference)
MDS対するWT1ペプチドワクチン療法第I相臨床試験
坪井 昭博, 川上 学, 保仙 直毅, 西田 純幸, 岡 芳弘, 尾路 祐介, 杉山 治夫
臨床血液 Vol. 51 No. 9 p. 948-948 2010/09
Publisher: (一社)日本血液学会-東京事務局WT1ペプチドがん免疫療法の現状と将来 造血器悪性腫瘍に対するWT1ペプチドがん免疫療法
坪井 昭博, 岡 芳弘, 尾路 祐介, 保仙 直毅, 西田 純幸, 中田 潤, 杉山 治夫
日本癌治療学会誌 Vol. 45 No. 2 p. 449-449 2010/09
Publisher: (一社)日本癌治療学会ウイルムス腫瘍遺伝子WT1の腫瘍血管内皮細胞における発現(WT1 expression in tumor endothelial cells)
福田 茉莉, 尾路 祐介, 中塚 伸一, 岡 芳弘, 坪井 昭博, 保仙 直毅, 西田 純幸, 辰巳 直也, 青笹 克之, 杉山 治夫
日本癌学会総会記事 Vol. 69回 p. 431-431 2010/08
Publisher: 日本癌学会担癌患者の骨髄中には末梢血に比較して癌抗原WT1特異的CD8+T細胞がより高頻度かつ未熟な状態で存在する
岡 芳弘, 村尾 綾子, 坪井 昭博, 田中 ゆきえ, 藤木 文博, 中島 博子, 西田 純幸, 保仙 直毅, 尾路 祐介, 杉山 治夫
日本がん免疫学会総会プログラム・抄録集 Vol. 14回 p. 57-57 2010/07
Publisher: 日本がん免疫学会INDUCTION OF COMPLETE AND MOLECULAR REMISSIONS IN ACUTE MYELOID LEUKEMIA BY WILMS' TUMOR 1 ANTIGEN-TARGETED DENDRITIC CELL VACCINATION
N. Berneman, A. van de Velde, S. Anguille, A. van Driessche, N. Cools, K. Vermeulen, K. Pieters, G. Nijs, B. Stein, W. Schroyens, A. Gadisseur, I. Vrelust, J. de Vries, Y. Oji, Y. Oka, H. Sugiyama, V. van Tendeloo
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL Vol. 95 p. 461-461 2010/06 Research paper, summary (international conference)
The WT1 gene: its functions and an oncogenic role in tumorigenesis
Vol. 61 No. 6 p. 594-600 2010
Publisher: 金原一郎記念医学医療振興財団骨髄異形成症候群における末梢血WT1 mRNA発現と抗WT1抗体産生の臨床的意義
田村秀人, 緒方清行, 横瀬紀夫, 岩切理歌, 大田雅嗣, 坂巻壽, 通山薫, 山下泰史, 近藤麻加, 兵働英也, 中村恭子, 尾路祐介, 杉山治夫, 檀和夫
臨床血液 Vol. 50 No. 9 p. 948-948 2009/09/30
Publisher: (一社)日本血液学会-東京事務局治療抵抗性婦人科癌を対象としたWT1ペプチドワクチン療法の有用性の検討
宮武 崇, 榎本 隆之, 白方 俊章, 岡 芳弘, 西田 純幸, 尾路 祐介, 保仙 直毅, 坪井 昭博, 上田 豊, 藤田 征巳, 青笹 克之, 森田 智視, 坂本 純一, 杉山 哲夫, 木村 正
日本癌治療学会誌 Vol. 44 No. 2 p. 415-415 2009/09
Publisher: (一社)日本癌治療学会MDSに対するWT1ワクチン療法
坪井 昭博, 岡 芳弘, 川上 学, 尾路 祐介, 保仙 直毅, 西田 純幸, 米谷 昇, 杉山 治夫
臨床血液 Vol. 50 No. 9 p. 948-948 2009/09
Publisher: (一社)日本血液学会-東京事務局グリベックとの併用によるCMLに対するWT1ペプチドワクチン免疫療法
尾路 祐介, 岡 芳弘, 西田 純幸, 白方 俊章, 保仙 直毅, 坪井 昭博, 中島 博子, 村尾 綾子, 杉山 治夫
臨床血液 Vol. 50 No. 9 p. 1226-1226 2009/09
Publisher: (一社)日本血液学会-東京事務局Prognostic impact of WT1 mutation in AML
Vol. 59 No. 2 p. 189-194 2009/08
Publisher: 科学評論社免疫モニタリング WT1 IgG抗体は非小細胞肺癌の早期診断および予後予測に有用なバイオマーカーとなりうる
尾路 祐介, 澤端 章好, 井上 匡美, 森 雅秀, 前田 元, 岡 芳弘, 奥村 明之進, 三好 新一郎, 杉山 治夫
日本がん免疫学会総会プログラム・抄録集 Vol. 13回 p. 112-112 2009/06
Publisher: 日本がん免疫学会WT1ペプチドワクチンと塩酸ゲムシタビンを併用した進行膵臓癌に対する新たな治療戦略
西田純幸, 武田裕, 岡芳弘, 小井戸薫雄, 本間定, 込田英夫, 伊藤壽記, 北川透, 坪井昭博, 尾路祐介, 中野晶子, 田中敏郎, 川瀬一郎, 森田智視, 坂本純一, 土岐祐一郎, 森正樹, 大草敏史, 田尻久雄, 杉山治夫
日本がん免疫学会総会プログラム・抄録集 Vol. 13th 2009/05/20
WT1 (WILMS TUMOR GENE) PEPTIDE VACCINATION FOR PATIENTS WITH RECURRENT GLIOBLASTOMA
Shuichi Izumoto, Akihiro Tsuboi, Yoshihiro Oka, Yasuyoshi Chiba, Naoki Kagawa, Naoki Hashimoto, Yusuke Oji, Haruo Sugiyama, Toshiki Yoshimine
NEURO-ONCOLOGY Vol. 11 No. 2 p. 225-226 2009/04 Research paper, summary (international conference)
Feasibility of WT1 peptide vaccination for the treatment of refractory hematological and solid malignancies in children
SAWADA Akihisa, INOUE Masami, KONDO Osamu, KIMOTO Tomiko, YAMADA Kayo, NAKAYAMA Masahiro, KUWAE Yuko, NISHIKAWA Masanori, OKAWA Hiroji, IDA Kohemi, TOKUDA Kiriko, MANABE Atsushi, TSUCHIYA Kunihiko, OKUYAMA Hiroomi, KUBOTA Akio, KAWAHARA Hisayoshi, HASEGAWA Toshimiti, YONEDA Akihiro, TAKEMOTO Osamu, YAMADA Junji, KAWABATA Hidehiko, TAMURA Daisuke, KINOUCHI Keiko, HIRANO Shinya, UNO Makoto, TAKESHITA Yasufumi, ISHIHARA Takashi, OKAMURA Takayuki, SAKATA Naoki, MIZUTANI Syuki, NAKAHATA Tatsutoshi, SAKO Masahiro, TAWA Akio, OJI Yusuke, TSUBOI Akihiro, KOYAMA Maho, OKA Yoshihiro, YASUI Masahiro, SUGIYAMA Haruo, KAWA Keisei
小児がん : 小児悪性腫瘍研究会記録 = Pediatric oncology Vol. 46 No. 1 p. 6-16 2009/02/25
Publisher: がんの子供を守る会造血器悪性腫瘍に対するWT1ペプチドワクチン療法:現状と今後の方向性
岡 芳弘, 坪井 昭博, 白方 俊章, 保仙 直毅, 西田 純幸, 尾路 祐介, 杉山 治夫
臨床血液 Vol. 50 p. 352-357 2009
Immunogenicity and Antileukemic Activity of Dendritic Cells Electroporated with Wilms' Tumor WT1 mRNA: A Phase I/II Trial in Acute Myeloid Leukemia
Zwi N. Berneman, Ann Van de Velde, Ann Van Driessche, Nathalie Cools, Barbara Stein, Griet Nijs, Katrien Vermeulen, Katrien Pieters, Wilfried A. Schroyens, Alain P. Gadisseur, Inge Vrelust, I. Jolanda de Vries, David A. Price, Yusuke Oji, Haruo Sugiyama, Viggo F. Van Tendeloo
BLOOD Vol. 112 No. 11 p. 308-308 2008/11 Research paper, summary (international conference)
がんワクチン療法標準化への提言 大腸癌、膵癌に対するWT1ペプチドワクチン療法
岡 芳弘, 西田 純幸, 武田 裕, 坪井 昭博, 尾路 祐介, 伊藤 壽記, 森田 智視, 坂本 純一, 関本 貢嗣, 杉山 治夫
Biotherapy Vol. 22 No. Suppl.I p. 68-68 2008/11
Publisher: (株)癌と化学療法社Safety, immunogenicity and antileukemic activity of dendritic cells electroporated with Wilms' tumor WT1 mRNA: A phase I/II trial in acute myeloid leukemia
Viggo F. Van Tendeloo, Ann Van de Velde, Ann Van Driessche, Nathalie Cools, Barbara Stein, Griet Nijs, Katrien Vermeulen, Katrien Pieters, Wilfried A. Schroyens, Alain P. Gadisseur, Inge Vrelust, I. Jolanda de Vries, David A. Price, Yusuke Oji, Haruo Sugiyama, Zwi N. Berneman
HUMAN GENE THERAPY Vol. 19 No. 10 p. 1069-1069 2008/10 Research paper, summary (international conference)
MRDを有する再発高リスク急性骨髄性白血病患者にWT1ワクチン療法行い5年以上の寛解を持続している3症例
坪井 昭博, 岡 芳弘, 西田 純幸, 保仙 直毅, 白方 俊章, 尾路 祐介, 村尾 綾子, 許 泰一, 片山 雄太
臨床血液 Vol. 49 No. 9 p. 900-900 2008/09
Publisher: (一社)日本血液学会-東京事務局グリベックとの併用によるCMLに対するWT1ペプチドワクチン免疫療法
尾路 祐介, 岡 芳弘, 西田 純幸, 白方 俊章, 保仙 直毅, 高橋 和子, 村尾 綾子, 中島 博子, 坪井 昭博, 杉山 治夫
臨床血液 Vol. 49 No. 9 p. 1011-1011 2008/09
Publisher: (一社)日本血液学会-東京事務局WT1ペプチドワクチンとIFN-βの併用投与によるWT1発現腫瘍に対する拒絶効果の増強
中島 博子, 岡 芳弘, 坪井 昭博, 保仙 直毅, 白方 俊章, 西田 純幸, 藤木 文博, 中野 晶子, 李 哲雨, 川瀬 一郎, 尾路 祐介, 杉山 治夫
基盤的癌免疫研究会総会抄録 Vol. 12回 p. 61-61 2008/06
Publisher: 日本がん免疫学会Single cell RT-PCR法を用いた、WT1ワクチン投与患者体内でのWT1特異的CTLクローンの動態解析
原田 ゆきえ, 岡 哲弘, 川上 学, 坪井 昭博, 白方 俊章, 西田 純幸, 保仙 直毅, 村尾 綾子, Elisseeva Olga, 李 哲雨, 森本 創世子, 中島 博子, 藤木 文博, 尾路 祐介, 川瀬 一郎, 杉山 治夫
臨床血液 Vol. 48 No. 9 p. 939-939 2007/09
Publisher: (一社)日本血液学会-東京事務局WT1ペプチドワクチン療法により長期に血液学的寛解を維持しているAML3症例
岡 芳弘, 坪井 昭博, 川上 学, 白方 俊章, 西田 純幸, 保仙 直毅, 許 泰一, 村尾 綾子, 中島 博子, 原田 ゆきえ, 藤木 文博, 土肥 博雄, 尾路 祐介, 川瀬 一郎, 杉山 治夫
臨床血液 Vol. 48 No. 9 p. 947-947 2007/09
Publisher: (一社)日本血液学会-東京事務局多発性骨髄腫に対してWT1ペプチドワクチンを行って有効であった一例
坪井 昭博, 岡 芳弘, 西田 純幸, 白方 俊章, 尾路 祐介, 杉山 治夫
臨床血液 Vol. 48 No. 9 p. 968-968 2007/09
Publisher: (一社)日本血液学会-東京事務局悪性脳腫瘍に対するWT1ペプチド免疫療法
杉山 治夫, 泉本 修一, 坪井 昭博, 香川 尚己, 鈴木 強, 橋本 直哉, 丸野 元彦, 尾路 祐介, 西田 純幸, 白方 俊章, 保仙 直毅, 川上 学, 森田 智視, 坂本 純一, 川瀬 一郎, 岡 芳弘, 吉峰 俊樹
Biotherapy Vol. 21 No. Suppl.I p. 70-70 2007/09
Publisher: (株)癌と化学療法社固形腫瘍に対するアポトーシス誘導剤としてのshRNA標的WT1 11AA(+)アイソフォームの可能性(shRNA targeting WT1 17AA(+) isoforms is a potent apotosis-inducing agent for solid tumors)
辰巳 直也, 尾路 祐介, 東尾 麻里, 中村 純也, 白方 俊章, 西田 純幸, 坪井 昭博, 岡 芳弘, 杉山 治夫
日本癌学会総会記事 Vol. 66回 p. 46-46 2007/08
Publisher: 日本癌学会Single cell RT-PCR法を用いた、WT1ワクチン投与患者体内でのWT1特異的CTLクローンの動態解析(analysis of dynamics of WT1-specific CTL clones in leukemia patients using single-cell RT-PCR method)
原田 ゆきえ, 岡 芳弘, 川上 学, 坪井 昭博, 西田 純幸, 白方 俊幸, エリセーバ・オリガ, 村尾 綾子, 藤木 文博, 中島 博子, 尾路 祐介, 川瀬 一郎, 杉山 治夫
日本癌学会総会記事 Vol. 66回 p. 337-337 2007/08
Publisher: 日本癌学会リアルタイムPCRを用いた担癌患者末梢血中のWT1特異的CD4陽性T細胞の定量的解析(Real-time PCR-based quantitative analysis of WT1-specific functional CD4+ T cells in tumor-bearing patients)
藤木 文博, 岡 芳弘, 川勝 真衣, 坪井 昭博, 原田 ゆきえ, 中島 博子, 李 哲雨, 西田 純幸, 白方 俊章, 保仙 直毅, 尾路 祐介, 杉山 治夫
日本癌学会総会記事 Vol. 66回 p. 337-337 2007/08
Publisher: 日本癌学会上顎下腺癌患者に対するWT1ペプチド癌ワクチン療法(WT1 peptide based immunotherapy for a patient with submaxillary gland cancer)
白方 俊章, 猪原 秀典, 岡 芳弘, 西田 純幸, 保仙 直毅, 坪井 昭博, 尾路 祐介, 川上 学, 川瀬 一郎, 久保 武, 杉山 治夫
日本癌学会総会記事 Vol. 66回 p. 338-338 2007/08
Publisher: 日本癌学会single-cell RT-PCR法を用いたWT1ペプチドワクチン投与患者体内でのWT1特異的CTLクローンの動態解析
原田 ゆきえ, 岡 芳弘, 川上 学, 坪井 昭博, エリセーバ・オリガ, 村尾 綾子, 西田 純幸, 白方 敏章, 保仙 直毅, 藤木 文博, 中島 博子, 李 哲雨, 尾路 祐介, 杉山 治夫
基盤的癌免疫研究会総会抄録 Vol. 11回 p. 71-71 2007/05
Publisher: 日本がん免疫学会Identification of CTL epitopes in hepatitis C virus by a genome-wide computational scanning and a rational design of peptide vaccine
Toshie Mashiba, Keiko Udaka, Yasuko Hirachi, Yoichi Hiasa, Tomoya Miyakawa, Yoko Satta, Tsutomu Osoda, Sayo Kataoka, Michinori Kohara, Morikazu Onji
IMMUNOGENETICS Vol. 59 No. 3 p. 197-209 2007/03
【造血器腫瘍と腫瘍免疫】 WT1を標的とした造血器腫瘍に対する免疫療法
岡 芳弘, 坪井 昭博, 川上 学, 白方 俊章, 西田 純幸, 尾路 祐介, 川瀬 一郎, 杉山 治夫
血液フロンティア Vol. 17 No. 3 p. 311-317 2007/02
Publisher: (株)医薬ジャーナル社WT1 (Wilms' tumor 1) peptide immunotherapy for renal cell carcinoma
Tatsuo Iiyama, Keiko Udaka, Sachihiko Takeda, Tamotsu Takeuchi, Yoshihiro C. Adachi, Yuji Ohtsuki, Akihiro Tsuboi, Shin-ichi Nakatsuka, Olga A. Elisseeva, Yusuke Oji, Manabu Kawakami, Hiroko Nakajima, Sumiyuki Nishida, Toshiaki Shirakata, Yoshihiro Oka, Taro Shuin, Haruo Sugiyama
MICROBIOLOGY AND IMMUNOLOGY Vol. 51 No. 5 p. 519-530 2007
Effective immune response induced by WT1 peptide vaccine
Olga Elisseeva, Yoshihiro Oka, Akihiro Tsuboi, Yukie Harada, Fumihiro Fujiki, Yusuke Oji, Haruo Sugiyama
JOURNAL OF IMMUNOTHERAPY Vol. 29 No. 6 p. 661-661 2006/11 Research paper, summary (international conference)
WTペプチドワクチンによる膠芽腫に対する癌免疫療法
坪井 昭博, 岡 芳弘, 丸野 元彦, 泉本 修一, 橋本 直哉, 大野 智, 西田 純幸, 尾路 祐介, 吉峰 俊樹, 杉山 治夫
日本補完代替医療学会学術集会プログラム・抄録集 Vol. 9回 p. 42-42 2006/10
Publisher: 日本補完代替医療学会骨髄異形成症候群(MDS)に対する少量WT1ペプチド療法
川上 学, 坪井 昭博, 西田 純幸, 白方 俊章, 原田 ゆきえ, 中島 博子, 藤木 文博, 李 哲雨, Elisseva Olga, 尾路 祐介, 古川 佳央, 林 孝昌, 岡 芳弘, 杉山 治夫
臨床血液 Vol. 47 No. 9 p. 1171-1171 2006/09
Publisher: (一社)日本血液学会-東京事務局腎細胞癌に対するWT1ペプチドワクチンを用いた臨床試験
白方 俊章, 飯山 達雄, 西田 純幸, 山上 学, 坪井 昭博, 尾路 祐介, 岡 芳弘, 野々村 祝夫, 奥山 明彦, 川瀬 一郎, 宇高 恵子, 執印 太郎, 杉山 治夫
日本癌学会総会記事 Vol. 65回 p. 323-323 2006/09
Publisher: 日本癌学会17AA(+)WT1遺伝子アイソフォームはintrinsic apoptosis pathwayに関与してアポトーシスを抑制する
尾路 祐介, 伊藤 憲, 白方 俊章, 清水 重臣, 辰巳 直也, 西田 純幸, 坪井 昭博, 辻本 賀英, 岡 芳弘, 杉山 治夫
臨床血液 Vol. 47 No. 9 p. 1158-1158 2006/09
Publisher: (一社)日本血液学会-東京事務局WT1ペプチド癌ワクチン投与患者末梢血中のWT1特異的CTLの解析
岡 芳弘, Elisseeva Olga, 長谷 浩志, 川上 学, 西田 純幸, 白方 俊章, 原田 ゆきえ, 中島 博子, 李 哲雨, 藤木 文博, 尾路 祐介, 川瀬 一郎, 坪井 昭博, 杉山 治夫
臨床血液 Vol. 47 No. 9 p. 1170-1170 2006/09
Publisher: (一社)日本血液学会-東京事務局WT1ペプチドワクチンによる膠芽腫に対する癌免疫療法
岡 芳弘, 泉本 修一, 坪井 昭博, 香川 尚己, 鈴木 強, 橋本 直哉, 丸野 元彦, 川上 学, 西田 純幸, 白方 俊章, 中島 博子, エリセーバ・オリガ, 原田 ゆきえ, 藤木 文博, 李 哲雨, 尾路 祐介, 森田 智視, 坂本 純一, 吉峰 俊樹, 杉山 治夫
Biotherapy Vol. 20 No. Suppl.I p. 138-138 2006/09
Publisher: (株)癌と化学療法社WT1ペプチド癌ワクチンを用いた膠芽腫に対する免疫療法
岡 芳弘, 泉本 修一, 坪井 昭博, 香川 尚己, 鈴木 強, 橋本 直哉, 丸野 元彦, 川上 学, 西田 純幸, 白方 俊章, 中島 博子, オリガ・エリセーバ, 原田 ゆきえ, 藤木 文博, 李 哲雨, 尾路 祐介, 森田 智視, 坂本 純一, 吉峰 俊樹, 杉山 治夫
基盤的癌免疫研究会総会抄録 Vol. 10回 p. 80-80 2006/06
Publisher: 日本がん免疫学会Extensive Educational Program for High Performance Medical Technologist
YORIFUJI S, IWATANI Y, KAWANO S, INAGAKI S, SUGIYAMA H, MATSUURA N, YAMANURA T, YAMAMOTO Y, HIGASHI T, HORIO M, OJI Y, YAMAGUCHI H, WATANABE M, KAWAGUCHI N, OHOKA Y, HIRATA M, ISHIGAMI M, EGUCHI H, HAMADA Y
The Official journal of Japanese Society of Laboratory Medicine Vol. 54 No. 3 p. 295-298 2006/03/20
Publisher: 日本臨床検査医学会事務所Serum levels of soluble interleukin-2 receptor is a powerful marker of acute graft-versus host disease after HLA-haploidentical bone marrow transplantation
K Kaida, K Ikegame, T Fujioka, Y Taniguchi, S Yoshihara, M Kawakami, H Hasei, S Nishida, T Masuda, M Murakami, EH Kim, A Tsuboi, Y Oji, Y Oka, T Shirakata, Y Kanakura, H Ogawa
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION Vol. 12 No. 2 p. 66-67 2006/02 Research paper, summary (international conference)
Development of WT1 peptide cancer vaccine against hematopoietic malignancies and solid cancers
Y. Oka, A. Tsuboi, M. Kawakami, O. A. Elisseeva, H. Nakajima, K. Udaka, I. Kawase, Y. Oji, H. Sugiyama
CURRENT MEDICINAL CHEMISTRY Vol. 13 No. 20 p. 2345-2352 2006 Book review, literature introduction, etc.
Phenotypical analysis of WT1-specific CTLs in WT1 vaccine-treated patients: An attempt to find immunological parameters that correlate with clinical response
O Elisseeva, Y Oka, A Tsuboi, H Hase, H Nakajima, Y Harada, M Kawakami, F Fujiki, Y Oji, H Sugiyama
JOURNAL OF IMMUNOTHERAPY Vol. 28 No. 6 p. 630-630 2005/11 Research paper, summary (international conference)
マウスの正常造血におけるWT1発現細胞の特性について
白方 俊章, 西田 純幸, 尾路 祐介, 川上 学, 坪井 昭博, 岡 芳弘, 川瀬 一郎, 杉山 治夫
日本血液学会・日本臨床血液学会総会プログラム・抄録集 Vol. 67回・47回 p. 791-791 2005/09
Publisher: 日本臨床血液学会WT1ペプチドワクチン療法により奉効した多発性骨髄腫の一例
坪井 昭博, 川上 学, 岡 芳弘, 西田 純幸, 白方 俊章, 大野 智, 中島 博子, 安川 正貴, 宇高 恵子, 尾路 祐介, 杉山 治夫
日本血液学会・日本臨床血液学会総会プログラム・抄録集 Vol. 67回・47回 p. 742-742 2005/09
Publisher: 日本臨床血液学会血縁者間HLA不適合骨髄移植における移植後急性期の血清中sIL-2R値と急性GVHDとの関係
海田 勝仁, 池亀 和博, 藤岡 龍哉, 谷口 裕紀, 吉原 哲, 川上 学, 長谷井 仁美, 西田 純幸, 升田 知機, 村上 雅樹, 金 義浩, 坪井 昭博, 尾路 祐介, 岡 芳弘, 金倉 譲, 小川 啓恭
日本血液学会・日本臨床血液学会総会プログラム・抄録集 Vol. 67回・47回 p. 784-784 2005/09
Publisher: 日本臨床血液学会17AA(+)WT1遺伝子アイソフォームの白血病細胞における抗アポトーシス機能
尾路 祐介, 伊藤 憲, 清水 重臣, 白方 俊章, 西田 純幸, 川上 学, 坪井 昭博, 岡 芳弘, 辻本 賀英, 杉山 治夫
日本血液学会・日本臨床血液学会総会プログラム・抄録集 Vol. 67回・47回 p. 822-822 2005/09
Publisher: 日本臨床血液学会WT1ペプチドを用いた消化器癌に対する免疫療法
尾路 祐介, 土岐 祐一郎, 関本 貢嗣, 坪井 昭博, 川上 学, 西田 純幸, 白方 俊章, 大野 智, 岡 芳弘, 青笹 克之, 門田 守人, 杉山 治夫
日本癌学会総会記事 Vol. 64回 p. 82-82 2005/09
Publisher: 日本癌学会同種移植後のノカルジア症
長谷井 仁美, 池亀 和博, 藤岡 龍哉, 吉原 哲, 川上 学, 海田 勝仁, 西田 純幸, 升田 知機, 村上 雅樹, 金 義浩, 坪井 昭博, 尾路 祐介, 金倉 譲, 小川 啓恭
日本血液学会・日本臨床血液学会総会プログラム・抄録集 Vol. 67回・47回 p. 864-864 2005/09
Publisher: 日本臨床血液学会同種移植後の肝障害に対するベザフィブラート療法
池亀 和博, 藤岡 龍哉, 谷口 裕紀, 吉原 哲, 川上 学, 長谷井 仁美, 海田 勝仁, 西田 純幸, 升田 知機, 村上 雅樹, 金 義浩, 坪井 昭博, 尾路 祐介, 岡 芳弘, 金倉 譲, 小川 啓恭
日本血液学会・日本臨床血液学会総会プログラム・抄録集 Vol. 67回・47回 p. 866-866 2005/09
Publisher: 日本臨床血液学会Wilms' tumour gene 1 (WT1) in human neoplasia
U Keilholz, HD Menssen, A Gaiger, A Menke, Y Oji, Y Oka, C Scheibenbogen, H Stauss, E Thiel, H Sugiyama
LEUKEMIA Vol. 19 No. 8 p. 1318-1323 2005/08 Book review, literature introduction, etc.
骨髄異形成症候群(MDS)に対する少量WT1ペプチド療法
川上 学, 坪井 昭博, 原田 ゆきえ, 中島 博子, 西田 純幸, 白方 俊章, 大野 智, 藤木 文博, 李 哲雨, オリガ・エリセーバ, 尾路 祐介, 古川 佳央, 岡 芳弘, 杉山 治夫
基盤的癌免疫研究会総会抄録 Vol. 9回 p. 83-83 2005/06
Publisher: 日本がん免疫学会Development of cancer vaccine targeting WT1 product which is expressed in various kinds of malignant neoplasms
Y. Oka, A. Tsuboi, O. A. Elisseeva, H. Nakajima, Y. Oji, H. Sugiyama
Medicinal Chemistry Reviews - Online Vol. 2 No. 6 p. 447-454 2005 Book review, literature introduction, etc.
Publisher: Bentham Science Publishers B.V.BCG-CWS enhances the potential of WT1 peptide cancer vaccine in mouse in vivo model
H Nakajima, Y Oka, A Tsuboi, M Kawakami, Y Oji, H Sugiyama
JOURNAL OF IMMUNOTHERAPY Vol. 27 No. 6 p. S37-S38 2004/11 Research paper, summary (international conference)
造血器悪性疾患に対するWT1ペプチド癌ワクチン療法
岡 芳弘, 坪井 昭博, 川上 学, 中島 博子, Elisseeva Olga, 呉 非, 池亀 和博, 吉原 哲, 西田 純幸, 升田 知機, 白方 俊章, 小川 啓恭, 藤木 文博, 許 泰一, 佐々木 絢子, 土肥 博雄, 尾路 祐介, 川瀬 一郎, 杉山 治夫
日本血液学会・日本臨床血液学会総会プログラム・抄録集 Vol. 66回・46回 p. 765-765 2004/09
Publisher: 日本臨床血液学会未処理haploidentical stem cell transplantationのおける検討
池亀 和博, 川上 学, 村上 雅樹, 藤岡 龍哉, 升田 知機, 谷口 裕紀, 西田 純幸, 高松 漂太, 吉原 哲, 白方 俊章, 金 義浩, 保仙 直毅, 玉置 広哉, 相馬 俊裕, 坪井 昭博, 尾路 祐介, 岡 芳弘, 金倉 譲, 小川 啓恭
日本血液学会・日本臨床血液学会総会プログラム・抄録集 Vol. 66回・46回 p. 832-832 2004/09
Publisher: 日本臨床血液学会HLA不適合骨髄移植後の出血性膀胱炎
藤 重夫, 池亀 和博, 川上 学, 村上 雅樹, 藤岡 龍彦, 升田 知機, 谷口 裕紀, 西田 純幸, 吉原 哲, 白方 俊章, 金 義浩, 玉置 広哉, 相馬 俊裕, 坪井 昭博, 尾路 祐介, 岡 芳弘, 金倉 譲, 小川 啓恭
日本血液学会・日本臨床血液学会総会プログラム・抄録集 Vol. 66回・46回 p. 837-837 2004/09
Publisher: 日本臨床血液学会WT1プロモーター/エンハンサー配列を用いた白血病細胞特異的遺伝子発現
中澤 務, 保仙 直毅, 柳原 正志, 金戸 啓介, 西田 純幸, 白方 俊章, 岡 芳弘, 尾路 祐介, 杉山 治夫
日本癌学会総会記事 Vol. 63回 p. 507-508 2004/09
Publisher: 日本癌学会T細胞除去を行わないHLA-haploidentical minitrasplantation
池亀 和博, 川上 学, 坪井 昭博, 村上 雅樹, 藤岡 龍哉, 升田 知機, 谷口 裕紀, 西田 純幸, 高松 漂太, 吉原 哲, 金 義浩, 保仙 直毅, 玉置 広哉, 尾路 祐介, 岡 芳弘, 杉山 治夫, 小川 啓恭
臨床血液 Vol. 44 No. 8 p. 674-674 2003/08
Publisher: (一社)日本血液学会-東京事務局WT1遺伝子の肺癌における過剰発現
尾路 祐介, 三好 新一郎, 新谷 康, 林 清二, 中塚 伸一, 中野 陽子, 浅田 桃太郎, 岡 芳弘, 小川 啓恭, 青笹 克之, 川瀬 一郎, 杉山 治夫
日本癌学会総会記事 Vol. 61回 p. 143-143 2002/10
Publisher: 日本癌学会肺癌において高発現されるWT1遺伝子は変異のない野生型である
高橋 英吾, 尾路 祐介, 三好 新一郎, 新谷 康, 林 清二, 中野 陽子, 杉山 治夫
日本癌学会総会記事 Vol. 61回 p. 244-245 2002/10
Publisher: 日本癌学会WT1遺伝子のpromoterとenhancerを用いた白血病細胞特異的な遺伝子発現
金戸 啓介, 保仙 直毅, 柳原 正志, 中澤 務, 西田 純幸, 岡 芳弘, 小川 啓恭, 尾路 祐介, 杉山 治夫
臨床血液 Vol. 43 No. 8 p. 131-131 2002/08
Publisher: (一社)日本血液学会-東京事務局Cellular and humoral immune responses against WT1 products overexpressed in hematopoietic malignancies
OKA Yoshihiro
Vol. 43 No. 7 p. 505-514 2002/07/30
Publisher: 日本臨床血液学会The combination of tacrolimus, methotrexate, and methylprednisone completely prevents acute graft-versus-host disease (GVHD) but not chronic GVHD, in unrelated bone marrow transplantation.
H Ogawa, T Soma, N Hosen, A Tsuboi, Y Oji, H Tamaki, M Kawakami, K Ikegame, M Murakami, T Fujioka, EH Kim, Y Oka, H Sugiyama
BLOOD Vol. 98 No. 11 p. 386B-386B 2001/11 Research paper, summary (international conference)
Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1) product
Y Oka, OA Elisseeva, A Tsuboi, H Ogawa, H Tamaki, HF Li, Y Oji, EH Kim, T Soma, M Asada, K Ueda, E Maruya, H Saji, T Kishimoto, K Udaka, H Sugiyama
IMMUNOGENETICS Vol. 51 No. 2 p. 99-107 2000/02
Successful treatment of relapsed T-cell non-Hodgkin's lymphoma with allogeneic peripheral blood stem cell transplantation with double conditioning
Y Oji, Y Oka, T Tatekawa, T Soma, T Matsunashi, T Yamagami, A Tsuboi, H Tamaki, EH Kim, H Sugiyama, H Ogawa
INTERNATIONAL JOURNAL OF HEMATOLOGY Vol. 69 No. 4 p. 263-267 1999/06
Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF)
A Tsuboi, Y Oka, H Ogawa, OA Elisseeva, H Tamaki, Y Oji, EH Kim, T Soma, T Tatekawa, M Kawakami, T Kishimoto, H Sugiyama
LEUKEMIA RESEARCH Vol. 23 No. 5 p. 499-505 1999/05
Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth
Y Oji, H Ogawa, H Tamaki, Y Oka, A Tsuboi, EH Kim, T Soma, T Tatekawa, M Kawakami, M Asada, T Kishimoto, H Sugiyama
JAPANESE JOURNAL OF CANCER RESEARCH Vol. 90 No. 2 p. 194-204 1999/02
WT1遺伝子と白血病
尾路 祐介, 小川 啓恭, 杉山 治夫
遺伝子医学 Vol. 2 No. 3 p. 450-452 1998/07
Publisher: メディカルドゥWilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells
K Inoue, H Tamaki, H Ogawa, Y Oka, T Soma, T Tatekawa, Y Oji, A Tsuboi, EH Kim, M Kawakami, T Akiyama, T Kishimoto, H Sugiyama
BLOOD Vol. 91 No. 8 p. 2969-2976 1998/04
Successful donor leukocyte transfusion at molecular relapse for a patient with acute myeloid leukemia who was treated with allogeneic bone marrow transplantation: importance of the monitoring of minimal residual disease by WT1 assay
H Ogawa, A Tsuboi, Y Oji, H Tamaki, T Soma, K Inoue, H Sugiyama
BONE MARROW TRANSPLANTATION Vol. 21 No. 5 p. 525-527 1998/03
Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia
K Inoue, H Ogawa, Y Sonoda, T Kimura, H Sakabe, Y Oka, S Miyake, H Tamaki, Y Oji, T Yamagami, T Tatekawa, T Soma, T Kishimoto, H Sugiyama
BLOOD Vol. 89 No. 4 p. 1405-1412 1997/02
Lineage- and differentiation stage-specific expression of LSM-1 (LPAP), a possible substrate for CD45, in human hematopoietic cells
Y Shimizu, H Sugiyama, Y Fujii, K Sasaki, K Inoue, H Ogawa, H Tamaki, S Miyake, Y Oji, T Soma, T Yamagami, M Hirata, K Ikeda, T Monden, T Kishimoto
AMERICAN JOURNAL OF HEMATOLOGY Vol. 54 No. 1 p. 1-11 1997/01
Nonomura, N. , Murosaki, N. , Kojima, Y. , Kondoh, N. , Seguchi, T. , Takeda, Y. , Oji, Y. , Ogawa, H. , Sugiyama, H. , Miki, T. , and Okuyama. : Secondary acute monocytic leukemia occuring during the treatment of a treatment of a testicular germ cell ・・・
Urologia Internationalis, in press. Vol. 58 No. 239-242 1997
Shimizu, Y. , Sugiyama, H. , Fujii, Y. , Sasaki, K. , Inoue, K. , Ogawa, H. , Tamaki, H. , Miyake, S. , Oji, Y. , Soma, T. , Yamagami, T. , Hirata, M. , Ikeda, K. , Monden, T. , and Kishimoto, T. : Lineage-and differentiation stage-specific expression ・・・
American Journal of Hematology, Vol. 54 p. 1-11 1997
Increased expression of the Wilms tumor gene (WT1) at relapse in acute leukemia
H Tamaki, H Ogawa, K Inoue, T Soma, T Yamagami, S Miyake, Y Oka, Y Oji, T Tatekawa, T Kitani, K Aozasa, T Kishimoto, H Sugiyama, H Miwa, K Kita
BLOOD Vol. 88 No. 11 p. 4396-4398 1996/12 Rapid communication, short report, research note, etc. (scientific journal)
Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels
K Inoue, H Ogawa, T Yamagami, T Soma, Y Tani, T Tatekawa, Y Oji, H Tamaki, T Kyo, H Dohy, A Hiraoka, T Masaoka, T Kishimoto, H Sugiyama
BLOOD Vol. 88 No. 6 p. 2267-2278 1996/09
WT1癌抑制遺伝子の, 白血病での異常発現とその意義
杉山 治夫, 井上 和司, 小川 啓恭, 玉置 広哉, 尾路 祐介, 岡 芳弘, 三宅 正剛, 山上 保, 相馬 俊裕, 岸本 忠三, 木村 貴文, 坂部 秀明, 薗田 精昭
日本分子生物学会年会プログラム・講演要旨集 Vol. 19 p. 704-704 1996/08/01
Tamaki, H. , Ogawa, H. , Inoue, K. , Soma, T. , Yamagami, T. , Miyake, S. , Oka, Oji, Y. , Y. , Tatekawa, T. , Tsuboi, A. , Tagawa, S. , Kitani, T. , Aozasa, K. , Miwa, H. , Kita, K. , Kishimoto, T. , and Sugiyama, H. : Increased expression of the Wilm・・・
Blood Vol. 88 p. 4396-4398 1996
骨髄移植と免疫抑制
尾路 祐介, 小川 啓恭, 杉山 治夫
最新医学 Vol. 50 p. 87-92 1995
Ogawa, H. , Sugiyama, H. , Tani, T. , Soma, Y. , Yamagami, T. , Tatekawa, T. , Oji, Y. , Kubota, T. , Kimura, T. , Inoue, K. , Nakagawa, M. , Sasaki, K. , Matsunashi, T. , Miyake, S. , and Kishimoto, T. : A high incidence of chemotherapy-induced acral ・・・
Leukemia and Lymphoma, in press.
Spontaneous high clonal expansion of Wilms’ tumor gene 1-specific cytotoxic T-lymphocytes in patients with Wilms’ tumor gene 1-expressing solid tumor
Morimoto Soyoko, Tanaka Yukie, Nakata Jun, Fujiki Fumihiro, Hasegawa Kana, Nakajima Hiroko, Nishida Sumiyuki, Tsuboi Akihiro, Hosen Naoki, Kagawa Naoki, Maruno Motohiko, Myoui Akira, Enomoto Takayuki, Izumoto Shuichi, Sekimoto Mitsugu, Hashimoto Naoya, Yoshimine Toshiki, Kumanogoh Atsushi, Oji Yusuke, Oka Yoshihiro, Sugiyama Haruo
Cancer Immunology, Immunotherapy Vol. 74 2024/11/07
Establishment of a novel platform cell line for efficient and precise evaluation of T cell receptor functional avidity
Morimoto Soyoko, Fujiki Fumihiro, Kondo Kenta, Nakajima Hiroko, Kobayashi Yoshiki, Inatome Miki, Aoyama Nao, Nishida Yuya, Tsuboi Akihiro, Oka Yoshihiro, Nishida Sumiyuki, Nakata Jun, Hosen Naoki, Oji Yusuke, Sugiyama Haruo
Oncotarget Vol. 9 No. 75 p. 34132-34141 2018/09/25
OVEREXPRESSION OF THE WILMS' TUMOR GENE WT1 IN DE NOVO LUNG CANCERS
尾路 祐介